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From first principles of phospholipid – apolipoprotein A-I (apo A-I) interactions, 
we hypothesized that the amino acid sequence of apo A-I derived from a different species 
may exhibit improved properties compared to human apo A-I for the purpose of 
incorporation of G protein-coupled receptors (GPCRs) into homogeneous discoidal 
lipoprotein particles. We generated apolipoprotein A-I DNA derived from zebrafish 
(Danio rerio) using molecular cloning techniques and optimized a heterologous bacterial 
expression system, and protein purification and labeling scheme for obtaining high-yields 
of pure zebrafish apo A-I. We demonstrated that zebrafish apo A-I forms stable, 
homogeneous discoidal lipoprotein particles, which we termed as Nanoscale 
Apolipoprotein Bound Bilayers (NABBs).  
Using bovine rhodopsin as a model system, we developed a novel method of 
rapidly incorporating GPCRs into NABBs – a significant improvement over traditional 
methods – requiring less time and materials for receptor reconstitution. The method was 
generalized for incorporation of heterologously expressed GPCRs in mammalian cells 
available at comparatively lower levels of receptor concentration and purity. A novel 
ELISA technique was developed for high-throughput quantification of the incorporated 
GPCR in NABBs. We also developed methods to control the ratio of receptor to NABB 
and imaged the rhodopsin-NABBs using electron microscopy (EM) to measure 
stoichiometry and receptor orientation.  
Using a combination of EM imaging and biochemical analyses, we correlated 
stability and signaling efficiency of rhodopsin in NABBs with either one or two 
receptors. We discovered that the specific activity of G protein coupling for single 
rhodopsins sequestered in individual NABBs was nearly identical to that of two 
rhodopsins per NABB under conditions where stoichiometry and orientation could be 
inferred by electron microscopy imaging. Thermal stability of rhodopsin and CCR5 in 
NABBs was superior to the receptors in various detergents commonly used for membrane 
protein work. CCR5 in NABBs retained its ability to activate G protein. This work 
highlights the NABBs as a promising tool for in-vitro manipulation of GPCR 












The important thing in science is not so much to obtain new facts  
as to discover new ways of thinking about them.  
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1.0   
Introduction 
1.1 G Protein-Coupled Receptors 
G Protein-Coupled Receptors (GPCRs) are integral transmembrane 
proteins that are known to transduce extracellular signals into intracellular 
functions and pathways (Filipek, Stenkamp et al. 2003). They form the largest 
and one of the most diverse groups of receptor proteins and are encoded by more 
than 1,000 genes in the human genome (Howard, McAllister et al. 2001). The 
signal transduction machinery in a cell is triggered by binding of an agonist ligand 
(or activation by light in the case of rhodopsin) at the extracellular side, followed 
by binding and activation of a guanine-nucleotide binding regulatory protein (G 
Protein) at the cytoplasmic side. A variety of chemical transmitters can elicit a 
cellular response via their related GPCR. These include biogenic amines 
(neurotransmitters), amino acids, peptides, lipids, nucleosides and large 
polypeptides. GPCRs thus control a wide range of physiological processes such as 
neurotransmission, cellular metabolism, secretion, cellular differentiation and 














































































































































































































































































































































































































































































































































































































































































































Not surprisingly, GPCRs are targets of a large number of therapeutic 
agents. It is estimated that 50% of all modern drugs (Howard, McAllister et al. 
2001) and almost one-quarter of the top 200 best-selling drugs in the year 2000 
modulated GPCR activity (George, O'Dowd et al. 2002). 
The membrane topology of GPCRs consists of a characteristic 
hydrophobic core of seven transmembrane -helices (Suryanarayana, von 
Zastrow et al. 1992), an extracellular amino-terminal segment and a cytoplasmic 
carboxy-terminal tail. Some GPCRs bear amine-linked glycosylation sites near 
their amino terminal tails. Ligand binding to GPCRs involves multiple 
interactions between functional groups and specific amino acids in the 
extracellular domains and/or the hydrophobic transmembrane core. Till recently, 
these interactions were well defined for only a few GPCRs (Bockaert and Pin 
1999). Over the last year, there have been an increasing number of reports of high 
resolution X-ray crystal structures of GPCRs (Cherezov, Rosenbaum et al. 2007; 
Jaakola, Griffith et al. 2008; Scheerer, Park et al. 2008; Shimamura, Hiraki et al. 
2008; Warne, Serrano-Vega et al. 2008). These structures have confirmed some 
key differences in structural elements compared with the prototypical GPCR –
bovine rhodopsin (Palczewski 2000; Huber, Menon et al. 2008), but have not 
been able to adequately explain the dynamic regulation and mechanism of action 
of the active state of the GPCR. 
Classically, the basic unit of signal transduction comprises the receptor, a 
heterotrimeric G protein and a downstream effector component. Binding of a 
5 
ligand promotes allosteric interactions between the receptor cytoplasmic side and 
the GDP-bound trimeric G protein leading to the release of GDP and binding of 
GTP to the -subunit. This destabilizes the trimeric complex, causing the 
dissociation of the G .GTP and the G  dimer. The G .GTP, the G  dimer or both, 
in turn interact with and modulate the effector component, often involving a 
second messenger. Termination of the signal occurs upon hydrolysis of GTP to 
GDP due to the GTPase activity of the G  subunit, aided by other GTPase 
activating proteins (GAPs). The signaling state of the receptor may be turned off 
either by ligand dissociation from the active conformation of the GPCR (in the 
case of rhodopsin), or phosphorylation of the cytoplasmic side followed by 
binding of a protein that is not G protein, or by receptor internalization into the 
cell. 
GPCRs have been classified into various subclasses based upon 
differences in the N and C-terminal regions and insertions in the cytoplasmic loop 
regions (Bockaert and Pin 1999). Rhodopsin is a defining member of family 1 (or 
family A) GPCRs characterized by comparatively short N- and C-termini. This 
family includes 2-adrenergic receptor, chemokine receptors, dopamine receptors 
and serotonin (5-HT) receptors. Most of the family A GPCRs have a 
palmitoylated cysteine in the C-terminal tail which serves as an anchor to the 
membrane. Family A GPCRs were all initially assumed to be monomeric, but 
some were able to form homodimers or heterodimers with another GPCR of the 
same class via their C-termini, or via contacts between the two 7TM cores 
(Chabre and le Maire 2005). Family 2 (or family B) GPCRs have a relatively long 
6 
N-terminal region which contains several cysteines forming a network of disulfide 
bridges, e.g- glucagon receptor. They are not palmitoylated at the C-terminus, 
unlike family 1. Family 3 (or family C) GPCRs have a long N-terminal extension 
folded in a separate extracellular domain as well as a C-terminal extension, e.g.- 
metabotropic glutamate receptor and the GABAB receptor. Family C GPCRs form 
constitutive homo or heterodimers, linked by disulfide bridges and associated 


























































































































































































































































































































































































































































































































































































































































1.1.1 Rhodopsin as the prototypical GPCR 
The dim-light visual receptor rhodopsin stands out as a model system for 
GPCRs, both in terms of GPCR structure and the downstream G protein signaling 
mechanism. Rhodopsin is located in the outer segments of retinal rod cells. 
Bovine rhodopsin is easily accessible, available in relatively large amounts and 
has an available high-resolution structure solved by X-ray crystallography 
(Palczewski, Kumasaka et al. 2000; Filipek, Teller et al. 2003). Rhodopsin in its 
dark state has the chromophore 11-cis-retinal covalently linked with Lys296 on 
helix 7 via a protonated Schiff base linkage, with Glu113 serving as the counter-
ion for the Schiff Base (Menon, Han et al. 2001). 11-cis-retinal serves as an 
inverse agonist and keeps the receptor in the inactive conformation in the dark. 
Bovine rhodopsin is sufficiently stable in the dark to be further purified by 
various chromatographic procedures and is thermally stable in solubilized form in 
a variety of detergents (De Grip 1982; Okada, Takeda et al. 1998).  
Upon absorption of a photon, the bound chromophore 11-cis-retinal 
undergoes a cis-trans conformational switch, which brings about a shift in the 
transmembrane helices. The isomerization of retinal leads to a series of 
conformational changes in the transmembrane helices (Farrens, Altenbach et al. 
1996), which include a counter-ion switch from Glu113 to Glu181 (Yan, Kazmi et 
al. 2003) to form metarhodopsin I (pre-active state), deprotonation of the Schiff 
Base to form the active state- metarhodopsin II (Fig. 1-2) and the disruption of a 
critical salt-bridge between Lys296 and Glu113 (Cohen, Oprian et al. 1992) to 
10 
form opsin. Metarhodopsin II (Meta-II) interacts with a G protein, called 
transducin, and activates it. This in turn activates (by de-inhibiting) a 
photoreceptor cGMP-specific phosphodiesterase (Stryer, Hurley et al. 1983).  
It is anticipated that the phototransduction signaling pathway involving 
rhodopsin and transducin will be the first G protein-coupled pathway for which a 
complete molecular description is ultimately available (Ridge, Abdulaev et al. 
2003). 
1.1.2 Chemokine Receptors 
Chemokine receptors are members of family A GPCRs and of significant 
clinical importance. Chemokines (chemotactic cytokines) constitute a superfamily 
of structurally related small proteins, less than 100 residues in length that are 
implicated in the control of a large variety of biological processes including 
inflammation, immunosurveillance, viral infection and cancer (Gerard and Rollins 
2001). Chemokines mediate their effects by binding to the chemokine receptors 
(Berger, Murphy et al. 1999; Rossi and Zlotnik 2000). The CXC and CC 
chemokines belong to different subfamilies where the two N-terminal cysteines 
are separated by a single amino acid and are adjacent to each other respectively. 
Examples of CC-chemokines include MIP-1  (Macrophage Inflammatory 
Protein-1 ), MIP-1  and RANTES (Regulated on Activation, Normal T-Cell 
Expressed and Secreted). All of these CC-chemokines bind non-selectively to 
CCR5 (Rossi and Zlotnik 2000).  
11 
CCR5 is an important co-receptor that is exploited for entry of HIV-1 
(Human Immunodeficiency Virus type 1) and is critical for the transmission of 
this virus in the body (Berger, Murphy et al. 1999) (Fig. 1-3). A naturally 
occurring CCR5 mutant (CCR5 32) results in a truncated receptor which leads to 
protection against HIV-1 in homozygous individuals and markedly reduced 
progress towards AIDS in individuals heterozygous for this mutation (Liu, Paxton 
et al. 1996; Samson, Libert et al. 1996; O'Brien and Moore 2000). No adverse 
health effects have been linked to the non-functional CCR5 in these individuals, 
which makes CCR5 a very attractive target for pharmaceutical intervention for the 
prevention of HIV/AIDS (O'Brien and Moore 2000). CCR5 homo and 
heterodimerization has been reported to have effects on CCR5 mediated HIV 
entry into cells. The dominant-negative phenotype of CCR5 32 over its wild-type 
counterpart have been attributed to the propensity of CCR5 32 to dimerize with 
wild-type CCR5 in the ER, thereby promoting intra-cellular retention of the 
heterodimers (Benkirane, Jin et al. 1997). An anti-CCR5 antibody that promotes 
dimerization has been reported to activate receptor dependent calcium 
mobilization and cell migration, but inhibit its use by HIV as a co-receptor for 
virus entry (Vila-Coro, Mellado et al. 2000). Heterodimerization of CCR5 with 
CCL2 has also been reported to block HIV entry (Rodriguez-Frade, del Real et al. 
2004).  
A CCR5 to CXCR4 switch has also been reported to accompany the onset 
of AIDS (Berger, Murphy et al. 1999). SDF-1 (Stromal cell-Derived Factor-1) is 
a CXC-chemokine and is expressed as two functionally identical, alternative 
12 
splice variants: SDF-1  and SDF-1  (Rossi and Zlotnik 2000), and binds to 
CXCR4. CXCR4 is expressed in hematopoeitic cell-lines (Zou, Kottmann et al. 
1998) and is thought to be involved in signaling responsible in part for stem-cell 
maturation, naive T-cell migration to spleen for antigen presentation and other 
developmental signaling (Proudfoot 2002). The SDF-1/CXCR4 system has been 
implicated in breast and ovarian cancers (Muller 2001; Scotton, Wilson et al. 

































































































































































































































































































































































































































































1.2 Rhodopsin Dimerization 
Despite an increasing number of reports of GPCR dimerization, the idea of 
rhodopsin existing as dimers in its native state remains one of the most 
controversial issues in the GPCR field. In this section, we review some of the 
notable experiments performed with rhodopsin pertaining to the nature of its 
organization in native and reconstituted systems. A comparison of key assays, and 
their possible pitfalls, used to detect dimerization in other GPCRs is also reviewed 
(see also section 5.3.4). 
Rhodopsin has been historically considered a monomer. One of the first 
reports of rhodopsin forming monomers in detergents came from rhodopsin 
solubilized in Triton X-100 (H. Beverley Osborne 1974) where it was determined, 
using ion-exchange chromatography and analytical ultracentrifugation, that 
protein-detergent complexes contained a single protein in approximately 80 
detergent molecules. The methods used in this study however, could not 
differentiate between a monomer or dimer in a detergent micelle. Determinations 
of protein molecular mass in other detergents by small-angle neutron scattering 
(Osborne, Sardet et al. 1978) have pointed at monomeric rhodopsin. The study 
also found that flash photoactivation of rhodopsin in certain types of polar 
detergents induced possible dimerization on a timescale of minutes. The slow 
16 
dimerization was followed by further oligomerization and eventual precipitation- 
a sign of protein denaturation in detergent. Dimerization and oligomerization of 
rhodopsin has not been observed in the native ROS membranes in the absence of 
detergents using small-angle neutron scattering (Saibil, Chabre et al. 1976). 
Formation of rho monomers or oligomers was shown to be dependent on the type 
of detergent used for solubilization of ROS (McCaslin and Tanford 1981). The 
oligomeric nature could be altered by varying the concentration of these 
detergents. In terms of G protein activation, it has been reported that 
photoactivated rho and holotransducin form a 1:1 complex in detergent, and that 
the photoactivated rho can activate hundreds of transducin molecules (Vuong, 
Chabre et al. 1984).  
The issue of rhodopsin dimerization came to the forefront of GPCR 
research primarily due to observations of associated rhodopsins as a row of 
dimers in AFM images of intact mouse disk membranes (Fotiadis, Liang et al. 
2003) (Fig. 1-4) and structural characterizations of crystal structures of rhodopsin 
(Salom, Lodowski et al. 2006). The dimerization reports have been contested as 
sample preparation (lipid phase change induced) problems (Chabre, Cone et al. 
2003) or crystallography artifacts. It has also been reported that transducin 
activity by rhodopsin dimers and olimers in detergents is significantly higher than 
by rhodopsin monomers (Jastrzebska, Maeda et al. 2004; Jastrzebska, Fotiadis et 
al. 2006). Moreover, opsin has been reported to be present as dimers on the 
surface of heterologously expressing COS cells (Kota, Reeves et al. 2006). 
Although the claims of rhodopsin dimerization, and the biological relevance of 
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this putative dimerization have been contested (Chabre and le Maire 2005; Ernst, 
Gramse et al. 2007), lack of an appropriate system for the study of one and two 
rhodopsins free from detergent-related aggregation artifacts and cellular 
overexpression have made the answer elusive.  
In order to investigate the existence of GPCR dimers in living cells, 
several groups have used biophysical assays based on light resonance energy 
transfer methods which are fluorescence resonance energy transfer (FRET) that 
uses fluorophores, or bioluminescent resonance energy transfer (BRET) using 
luciferase or green fluorescent protein (GFP) containing GPCR constructs 
(Bouvier 2001; Bartfai, Benovic et al. 2004). Close proximity between GPCRs 
containing complementary labels causes energy transfer from a donor to an 
acceptor molecule resulting in the appearance (in BRET) or enhancement of the 
emission signal (in FRET) of the acceptor molecule. It is plausible that using 
comparatively large labels like luciferase and GFP (~25 kD) on GPCRs (~40 kD) 
may itself influence trafficking of the GPCR as well as dimerization either 
directly or via accessory proteins. Further, constraints on the assumed distance 
dependency of these methods have been seen. Heterodimerization between 2-
adrenergic receptor and -opioid receptors were detected with co-
immunoprecipitation but not with BRET and FRET, whereas homodimerization 
could be detected with all three methods (McVey, Kellet et al. 2001). 
Overexpression of GPCRs in cells has been reported to cause significant BRET 
signal attributed to transient, non-specific interactions (James, Oliveira et al. 
2006). Finally, the issue of interpreting ligand-mediated dimerization of GPCRs 
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in cells is non-trivial. Both BRET and FRET are sensitive to the dipole orientation 
of their respective labels and conformational changes induced by ligand binding 
may change the dipole orientation such that a signal is seen independent of any 
change in the distance between the receptors (Bouvier 2001). 
Investigation of dimerization of GPCRs therefore, will benefit from 
validation of cell-based assays using a combination of ensemble biochemistry, 
single-particle imaging and novel receptor assays in a cell-free system.  
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Figure 1-4. AFM Image and Models for Rhodopsin Dimerization 
 
(A) Topographic image of the cytoplasmic side of rhodopsin 
obtained by Atomic Force Microscopy (AFM) on native disc membranes. 
Rows of rhodopsin dimers are seen in a paracrystalline array. The dashed 
ellipse shows isolated dimers and the arrows show rho monomers. The 
scale bar is 15nm. Image adapted from Fotiadis et al. (Fotiadis, Liang et 
al. 2003). (B) Model of the side view model of a rho dimer. Contact 
between the monomers is formed by transmembrane helices IV 
(yellowish-green) and V (yellow). The dimer interface consists of 
hydrophobic interactions and hydrogen bonds. Model taken from Fotiadis 
et al. (Fotiadis, Liang et al. 2004). (C) Model of the packing arrangement 
of rho in paracrystalline arrays. Rho assembly in a ‘row of dimers’ state by 
contacts between helices IV and V (contact 1). The rows formed by 
dimers are highlighted by blue bands. The rows are thought to be formed 
due to contacts between the cytoplasmic loop connecting helices V and VI 
(C 3) on one dimer and helices I and II (C 1) on the other dimer (contact 
2). Rows form paracrystals by extracellular contacts through helix I 
(contact 3). Image taken from Liang et al. (Liang, Fotiadis et al. 2003). 
(D) Another depiction of the ‘row of dimers’ model. Helix ends are shown 
in different colors. Image taken from Fotiadis et al. (Fotiadis, Liang et al. 
2004). 
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1.3 The Importance of Lipids 
Lipids as a class of molecules display a wide diversity in both 
structure and biological function. The propensity of hydrophobic lipid tails to self-
associate (entropically driven by water), and the tendency of the hydrophilic 
moieties to interact with aqueous environments and with each other, is the 
physical basis of the spontaneous formation of the lipid bilayer membrane. The 
membrane is the supporting matrix for a wide spectrum of proteins involved in 
many cellular processes. Lipids also allow particular proteins in membranes to 
aggregate, and others to disperse. Approximately 20-35% of all proteins are 
integral membrane proteins, and probably half of the remaining proteins function 
at or near a membrane surface.  Because of their relatively reduced state, lipids 
are used for energy storage in lipid droplets as triacylglycerol and steryl esters 
(van Meer, Voelker et al. 2008). Lipids may also act as first and second 
messengers in signal transduction and molecular recognition processes. The 
adaptability and flexibility exhibited in membrane structure and function is 
possible only with a broad spectrum of lipid mixtures (Dowhan 1997). Therefore, 
the physical and chemical properties of the membrane directly affect most cellular 
processes making the role of lipids dynamic with respect to cell function rather 































































































































































































































































































































































































































































































































































































































































































































































1.3.1 Discoidal HDL Particles to Study Membrane Proteins 
The formation of discoidal structures of lipids surrounded by human 
apolipoprotein A-I (apo A-I) was first demonstrated in 1980 (Jonas and Drengler 
1980), after similar structures were implicated in transport of cholesterol by High 
Density Lipoproteins (HDL) in the serum (Jonas, Krajnovich et al. 1977). More 
recently, an engineered N-terminal truncated form of human apo A-I was used in 
a similar manner to incorporate peripheral and integral membrane proteins into 
such bilayer nano discs (Bayburt, Grinkova et al. 2002; Bayburt and Sligar 2002; 
Bayburt and Sligar 2003).  
Nanoscale discoidal lipoproteins with incorporated GPCRs are an ideal 
system for spectroscopy. The discrete lipid discs prevent aggregation phenomena 
as seen with detergent micelles, light-scattering of lipid vesicles and provide a 
system that can be isolated in monodisperse form with the phospholipid-protein 
native structure and function maintained. The nanoscale lipid disc with embedded 
protein can be versatilely adapted for assays involving either immobilization or 
constant flow of the discs over a surface. The protein-lipid complex will behave 
more or less like normal proteins in solution without foaming or sedimentation 
problems associated with detergents and vesicles. 
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Figure 1-6. X-Ray Crystal Structures of Human Apo A-I 
 
High-resolution x-ray structures are available for human apo A-I 
(1-43 amino acids truncated) as well as full-length protein. (A) 4Å 
structure of residues 44-243 of human apo A-I from Borhani et al. 
(Borhani, Rogers et al. 1997). N-terminal truncation of apo A-I resulted in 
crystallization of a tetramer in a unit cell shown in the right panel. Apo A-
I monomer (left) and dimer (center) are also shown. Dimeric crystal 
contacts were formed along helix 10 of two anti-parallel apo A-I 
molecules (center). (B) Domain representation of human apo A-I from Li 
et al. (Li, Chen et al. 2004). The N-terminal 43 amino-acids are 
considered to form a globular, flexible domain and important for 
activation of Lecithin Cholesterol Acyl Transferase (LCAT) enzyme in the 
reverse cholesterol transport pathway. (C) Domain representation and x-
ray structure of full-length human apo A-I adapted from Ajees et al. 
(Ajees, Anantharamaiah et al. 2006). The N-terminus forms a helix among 
a four helix bundle. Notably, the structure shows six total helices, 
indicating that every proline residue in the sequence may not always cause 
kinks in the helices. 
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In-vitro assays avoid several artifacts and assumptions inherent to in-vivo 
systems. Detergents offer the first choice to isolate transmembrane proteins from 
their cellular context. In a sense, both detergents and lipids are surfactants. What 
distinguishes one from the other are the concentration regimes for self-association 
and the kinds of multimolecular structures each can make. The problem of 
isolating native membrane proteins from lipid bilayers and then subsequently 
manipulating them is, in essence, a problem of dealing with mixed surfactant 
systems. However most GPCRs retain function in only a limited number of 
detergents, which typically have a relatively low critical micelle concentration 
and a relatively large micelle size. This gives rise to aggregation phenomena 
(Jastrzebska, Maeda et al. 2004) and is a potential source of irreproducibility 
while performing spectroscopic measurements. Vesicles form closed structures 
and the chemical composition of the lumen is difficult to alter. Lipid vesicles are 
also prone to light scattering artifacts in optical spectroscopy and a precise control 
of the number of receptors per vesicle, and heterogeneity of vesicle sizes, are 
difficulties. A further complication, when the GPCR is reconstituted in a vesicle, 




Figure 1-7. Double-belt Model and Salt-Bridging in Discoidal 
Lipoprotein Particles  
 
(A) Molecular model of a ‘double-belt’ conformation of N-
terminal 1-43 amino-acid truncated version of human apo A-I with a 
simulated POPC bilayer, from Segrest et al. (Segrest, Jones et al. 1999). 
The helical ribbons are based on the x-ray structure of N-terminally 
truncated human apo A-I (Borhani, Rogers et al. 1997) and arranged 
antiparallel with respect to each other with helix 5 of monomer 1 
associated with helix 5 of monomer 2 (LL5/5 configuration). (B) Space-
filling molecular graphics model of human apo A-I 1-43, from Segrest et 
al. (Segrest, Li et al. 2000). The apo A-I is viewed with the plane of the 
disc parallel to the paper. Hydrophobic residues are indicated in orange, 
prolines in green, basic residues in blue and acidic residues in red. The 
amphipathic nature of the -11/3 ring can be clearly seen in this depiction. 
(C) Molecular Dynamics simulation at 4.5 nsec of a single 
bacteriorhodopsin embedded in a HDL particle containing DPPC lipids. 
The two molecules of human apo A-I 1-43 are shown in blue and red in 
this figure from Shih et al. (Shih, Denisov et al. 2005). (D) Structure and 
interhelical salt bridging between apo A-I helices arranged in the LL5/5 
configuration, taken from Segrest et al. (Segrest, Jones et al. 1999). (E) 
Weighed interhelical salt-bridging score analysis of the C-terminal 200 
amino acids of human apo A-I and zebrafish apo A-I. 2 molecules of apo 
A-I were considered to be in -11/3 helical conformation and the salt 
bridging score was computationally calculated using the ALIGN program 
in this figure adapted from Segrest et al. (Segrest, Jones et al. 1999). (F) 
An example of a salt-bridging triad observed in a apo A-I rotamer by MD 
simulation, from Klon et al. (Klon, Segrest et al. 2002). 
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Figure 1-7. Double-belt Model and Salt-Bridging in Discoidal 








1.4 Signal Transduction Events Proximal to the GPCR 
There are no known prokaryotic homologs of GPCRs (unlike ion-
channels), hence the closest substitute to their native environment has been 
assumed to be the cell membrane of eukaryotic cell lines like HEK293, Sf9, COS 
and CHO cells. Cell-based assays, for example those measuring second 
messenger levels, like cAMP, Ca2+ or IP3 in response to stimulation of a GPCR, 
monitor signaling at very distal points but do not provide direct information about 
the events going on more proximally; that is, at the G protein level. In fact, ligand 
efficacies and potencies measured at the G protein level and at the effector level 
in a given signaling cascade can be quite different (Seifert, Wenzel-Seifert et al. 
1999). GPCR-dependent functions other than ligand-receptor binding might give 
a signal that might be construed as an affirmative response to ligand binding. 
These signals may be due to compounds acting on GPCRs like regulator of G 
protein signaling-4 (RGS4), accessory proteins like receptor-activity-modifying 
proteins (RAMPs), or receptor dimerization. Overexpression of the receptor can 
lead to aberrant responses due to inappropriate stoichiometry of these proteins. 
There may be a lack of reproducibility in-vivo, in particular regarding signaling 
from cells transfected with high levels of a GPCR. Finally, it is entirely possible 
that GPCR signaling in-vivo is influenced by its location within signaling 
complexes that are cell-type specific (Steinberg and Brunton 2001; Luttrell and 
Lefkowitz 2002). Cell based assays have the advantage that they can be adapted 
in a relatively straightforward way for high throughput screening of compounds; 
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by binding competition assays for instance. An alternative system for studying 
ligand-receptor, or receptor-G protein phenomena will have to discard the 
presence of ‘interfering’ players and phenomena mentioned above, while 
maintaining the native-like lipid environment for the receptor and preserving the 
advantages of simplicity and high-throughput screening. GPCRs, like most other 
complex membrane proteins, are dependent on a lipid environment for structural 
stability and integrity. The importance of a lipid environment is exemplified in 
literature reports which exemplify profound effects of different membrane lipids 
on functional parameters of rhodopsin (Botelho, Gibson et al. 2002; Botelho, 
Huber et al. 2005). Furthermore, a lipid environment has been reported to 
enhance G protein binding to the activated GPCR compared with detergents 
(Melia, Malinski et al. 2000; Zhang, Melia et al. 2004).  
Biophysical studies of GPCRs have been indispensable in providing 
knowledge of ligand-dependent conformational states of a receptor (Imamoto, 
Kataoka et al. 2000; Ghanouni 2001; Devanathan, Yao et al. 2004), intermediate 
conformations adopted by the receptor upon activation (Palanche 2001; 
Swaminath 2004) and receptor oligomerization (Bouvier 2001; George, O'Dowd 
et al. 2002; Mercier, Salahpour et al. 2002; Fotiadis, Liang et al. 2004). The 
majority of the biophysical studies on GPCRs have been done on receptors 
solubilized in detergent micelles, reconstituted in lipid vesicles or overexpressed 
on the cell surface. A monodisperse, soluble form of the receptor, although 
convenient for in-vitro assays, does not usually provide a native environment of 
the receptor and thereby makes an underestimation of the role of native membrane 
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lipids in the modulation of GPCR function. Molecular assays that directly report 
G protein activation and conformational changes undergone by the receptor in a 
controlled lipid environment could bridge the gap between the limited information 
obtained from simple binding assays in detergents and the complexity of cell-
based systems.  
A crystal structure provides a high-resolution snapshot of a single receptor 
conformation, often with some artifactual elements. Although it gives a wealth of 
information, x-ray crystallography alone is unlikely to be sufficient in elucidating 
the dynamic picture of agonist binding, receptor oligomerization and G protein 
interactions in the native state of the GPCR. The organization of GPCR systems 
and signaling complexes is still an open question. Even in the case of rhodopsin, 
the field is sharply divided on the question of whether it is dimeric in its native 
membrane. Therefore, we developed the NABB system as a platform to study G 
protein activation by either one (monomer) or two (putative dimer) rhodopsins 
isolated and purified in a soluble lipid bilayer. We performed characterization 
experiments, including electron microscopy imaging of the particles with one or 
two rhodopsins and we proposed the relative limits of G protein activity of a 
putative rhodopsin dimer with respect to that of the monomer. We also show that 
our strategy of GPCR reconstitution may be applied to a different heterologously 
expressed GPCR – called CCR5, and that CCR5 reconstituted in NABBs retain 
their native conformation and G protein activity.  
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2.0   
Materials and Methods 
2.1 Reagents and Buffers 
Oligonucleotide primers were obtained from GeneLink (NJ), restriction 
endonucleases from New England Biolabs (Ipswich, MA). Lipids were obtained 
from Avanti Polar Lipids (Alabaster, AL). Detergents were obtained from 
Anatrace Inc (Maumee, OH). Fluorescent dyes were obtained from Invitrogen 
(Carlsbad, CA). All buffer reagents obtained from Sigma-Aldrich Inc. (St. Louis, 
MO). Electron microscopy stains and grids were obtained from Electron 
Microscopy Sciences (Hatfield, PA). All UV-visible absorption spectroscopy 
experiments were performed in a Perkin-Elmer Lamda 800 UV-visible 
spectrophotometer. 
The following buffers were used in the methods followed in this project:  
Buffer T: 25 mM Tris pH 8, 125 mM NaCl, 1 mM NaN3. 
Buffer H1: 25 mM HEPES-MES-KOH pH 6.9, 125 mM KCl, 2 mM MnCl2,  
2 mM CaCl2, 1 mM EDTA. 
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Buffer H2: 10 mM HEPES-MES-KOH, 100 mM KCl. pH adjusted from 6.9 by 
using either 1 N HCl (more acidic pH) or 1 N KOH (more basic). 
Buffer N1: 20 mM Tris pH 7, 0.1 M (NH2)SO4, 10% glycerol, 0.07% CHS, 
0.018% DOPC, 0.008% DOPS, 0.33% DM. 
Buffer P1: 20 mM Tris pH 8, 1% (w/v) POPC, 0.01% (w/v) NBD-DPPE,  
1% (w/v) CHAPS. 
Buffer P2: 20 mM Tris pH 8, 0.6% (w/v) POPC, 0.4% POPS, 0.01% (w/v) NBD-
DPPE, 1% (w/v) CHAPS. 
Buffer G1: 20 mM HEPES-MES-KOH pH 6.9, 0.3 M NaCl, 5 mM MgCl2,  
5 μM GDP. 
Buffer G2: 20 mM Tris pH 8, 0.3 M NaCl, 5 mM MgCl2, 5 μM GDP,  
1 mM DTT. 
Buffer GM1: 50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT. 
Buffer GM2: 50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT, 1.2 M (NH4)2SO4,  
25 μM GDP. 
Buffer GM3: 50 mM Tris pH 8, 1 mM EDTA, 1 mM DTT, 35% glycerol,  
25 μM GDP. 
Buffer R1: 30% (w/w) sucrose, 10 mM Tris-acetate pH 7.4, 130 mM NaCl,  
0.4 mM MgCl2, 0.4 mM EDTA. 
Buffer ISO: 20 mM Tris pH 7.1, 120 mM KCl, 60 mM NaCl, 10 mM MgSO4,  
2 mM DTT, 0.1 mM PMSF. 
Buffer HYPO: 5 mM Tris pH 7.1, 5 mM Mg(CH3COO)2. 
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Buffer BG1: 10 mM sodium phosphate pH 6.5, 2 mM MgCl2, 0.1 mM EDTA,  
1 mM DTT, 10% (w/v) glycerol. 
2.2 Isolation and Purification of Rhodopsin 
Rod Outer Segment (ROS) membranes were isolated from frozen dark-
adapted bovine retinae (W.L. Lawson Co., NE; Ph: 402-466-0492) using a 
modification of previously reported procedure (Papermaster 1982). All steps were 
carried out in the dark or under dim red light. Foil-wrapped vials containing 100 
retinae were thawed in a water bath for 1 h. The retinae were placed in a dounce 
homogenizer and flushed with Ar for 5 min. 60 mL of buffer R1 was added to the 
retinae and the solution was homogenized 10 times very slowly with Ar flush 
between the strokes. The retina solution was transferred to Ti-45 centrifuge tubes 
(50mL per tube), flushed with Ar and centrifuged at 4k rpm, 20 min, 4°C. The 
supernatant was collected and the pellet was re-homogenized by adding equal 
volume of buffer R1 and applying 6-8 strokes of the homogenizer, and the 
centrifugation repeated. The supernatants were combined in a beaker on ice and 2 
volumes of 10 mM Tris-acetate pH 7.4 were added while stirring the solution 
under Ar. The combined supernatants were centrifuged in a Ti-45 rotor at 7k, 50 
min, 4°C. The pellet was preserved. A three-step sucrose gradient was prepared in 
polyallomer centrifuge tubes for the Beckman SW-28 rotor. Sucrose densities of 
1.15 g/mL (8mL), 1.13 g/mL (10mL) and 1.11 g/mL (10 mL) were used. 1.10 
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g/mL sucrose solution was used to resuspend the ROS pellet in a total of 25mL 
and this solution was distributed to bring the polyallomer tubes to final volume. 
The tubes were flushed with Ar and the SW-28 rotor was centrifuged at 24k, 1 h, 
4°C. The band at the interface of 1.11/1.13 g/mL sucrose was harvested (highest 
purity of ROS). The collected bands were pooled and diluted with 2 volumes of 
water and distributed to Ti-45 tubes, flushed with Ar and centrifuged at 25k, 30 
min, 4°C. The pellet was washed with water and the centrifugation repeated 
twice. After the final wash, the pellet was resuspended in 67 mM sodium 
phosphate pH 7.0. The ROS was dispensed as 500μL aliquots and stored wrapped 
in foil at –80°C. Using this protocol, approximately 45 mg of ROS was obtained 
at 5.6 mg/mL rhodopsin at a A280/A500 ratio of 3. 
To purify rhodopsin from ROS, a membrane aliquot was thawed and 
solubilized with 2.5mL of 1.5% Octyl Glucoside (OG) containing buffer H1 
(Solubilization buffer) for 2-3 hours at 4°C on a nutator. The solution was then 
centrifuged in a Beckman Type 50 rotor at 34,000 rpm for 10 min at 4°C. The 
supernatant was added to 1mL cross-linked ConA-sepharose beads and nutated 
for 1 h at 4°C. The beads were washed with Solubilization buffer and elution was 
done using 100mM -methyl mannoside in 1.5% OG containing buffer H1. 
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2.3 Site-specific Labeling of Rhodopsin with Fluorophores 
Fluorophore labeling of rhodopsin was done on ROS membranes with 
fluorophores functionalized with a maleimide group. The ROS used had a 
rhodopsin concentration of 187 μM and absorbance 280nm/500nm ratio of 2.0. 
The labeling reactions were carried out in a dark room under dim red light. The 
fluorophores were stored as a 22 mM stock in DMSO at –20°C. The optimal 
fluorophore to rhodopsin ratio at the start of the labeling reaction was determined 
experimentally for different fluorophores. Typically, three different molar ratios 
of dye to rhodopsin were used- 1:1, 3:1, 9:1. Each labeling reaction had ROS 
containing 1.2 mg rhodopsin (163μL aliquot of the ROS) in 0.6mL tubes. After 
addition of the appropriate volume of fluorophore stock, the tubes were flushed 
with Ar and incubated for 12.5 h at 28°C with shaking in a thermomixer. The 
reaction was terminated by adding 5 mM DTT to each tube and incubating on ice 
for 10-15 min. The excess label was washed from the ROS using three washes of 
1% BSA containing buffer H1. The ROS was then transferred to a 15mL tube 
containing 2mL of 1.5% OG containing buffer H1 (Solubilization buffer) and kept 
on a nutator for 1 h at 4°C. The solution was then transferred to centrifuge tubes 
and centrifuged in a Beckman Type 50 rotor at 34,000 rpm for 10 min at 4°C. The 
supernatant was added to 1mL cross-linked ConA-sepharose beads and nutated 
for 1 h at 4°C. The beads were washed with Solubilization buffer 4-5 times, or till 
coincident UV-vis spectra were obtained from subsequent washes. The rho was 
eluted from the ConA beads using 100mM -methyl mannoside in 1.5% OG 
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containing buffer H1, then pooled and concentrated using a centrifugal 
concentrator with 10k MWCO. The final rho concentration was determined by 
UV-vis difference spectral scan from 700nm to 250nm before and after 
photobleaching the sample with yellow light. The stoichiometry of labeling was 
determined by comparing the molar concentration of label and rho in the cuvette.  
Site-specificity of labeling at a single accessible cysteine was confirmed 
by digestion of labeled rhodopsin by V8 protease (Farrens, Altenbach et al. 1996) 
and detecting labeled fragments on SDS-PAGE. V8 protease was added to rho in 
1.5% OG buffer H1 at a molar ratio of 1:30. The mixture was incubated for 1.5 h 
at 30°C and the fractions were analyzed by SDS-PAGE. The fluorescence in the 
lanes of the gel was detected by a Typhoon 9400 imager (GE Healthcare) and the 
gel was subsequently stained with Coomassie Blue to detect protein bands.  
2.4 Labeling of Rhodopsin with Nanogold 
Nanogold labeling of rhodopsin was also performed on ROS membranes 
using monomaleimido nanogold (Nanoprobes, Yaphank, NY) using manufacturer 
recommended conditions and concentrations. A 9:1 (M/M) ratio of 
monomaleimido nanogold to rhodopsin was used, with 2.5mg of rho in ROS. The 
mixture was incubated at 28°C for 16 h without shaking. The labeled rhodopsin 
was purified as described in Method 2.3. The labeling stoichiometry was 
determined by comparing the characteristic absorbance of nanogold at 420nm 
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with rhodopsin absorbance at 500nm determined by UV-vis difference 
spectroscopy and was found to be 0.8-0.9 (M/M) Nanogold/rhodopsin.  
2.5 Isolation and Purification of Holotransducin 
Frozen, dark-adapted bovine retinae (200 retinae in vials) were thawed in 
a room temperature water bath for 30 min. 100mL cold ISO buffer was added 
with protease inhibitors and stirred on an ice-bath for 30 min. The slurry was 
filtered through a metal filter in batches. The volume was increased to 200mL 
with ISO buffer. The solution was layered onto a 37% (w/w) sucrose cushion in 
centrifuge tubes for a Beckman SW-28 rotor. Each tube contained 13mL of 37% 
sucrose and 25mL retina slurry. The tubes were centrifuged in a SW-28 rotor at 
22k rpm, 25 min, accel/decel 6/6 at 4°C. The tubes were opened in the dark room 
and black bands at the interface of the sucrose and slurry were collected with an 
18G needle and 10mL syringes. The volume of the collected bands was increased 
to 250mL using cold ISO buffer. The sucrose cushion step was repeated and the 
band at the same location of the tube was collected. Cold ISO buffer was added to 
increase the volume of the collected bands to 200mL. The solution was 
distributed in Ti-45 centrifuge tubes. The solution was centrifuged for 28k rpm, 
20 min, 4°C. The reddish-orange pellet was resuspended in 200mL total ISO 
buffer using a dounce homogenizer. The slurry was transferred to a beaker kept 
on ice and illuminated from below with >495nm light with constant stirring for 20 
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min. The illuminated slurry was distributed into Ti-45 tubes (50mL per tube) and 
centrifuged at 30k, 20 min, 4°C. The pellet was then resuspended in HYPO buffer 
and homogenized using the dounce homogenizer. The centrifugation and 
homogenization steps were repeated with increasing centrifugation speeds each 
time- 32k, 36k, 40k for 20 min, 4°C. Holotransducin (Gt) was extracted from the 
ROS membranes by adding 200 μM GTP containing HYPO buffer and incubating 
on ice for 10 min. The slurry was centrifuged at 42k, 20 min, 4°C and the 
supernatant was collected. The total volume of the extractions was kept under 
150mL. The pooled GTP extractions were centrifuged at 42k, 20 min, 4°C to 
remove any residual membranes. The extract was then loaded on a hexylagarose 
column (25mL hexylagarose packed in a GE Healthcare XK 16/20 column) at 
0.25mL/min at 4°C equilibrated with HYPO buffer. The hexylagarose column 
was washed sequentially with HYPO buffer, 75 mM NaCl containing HYPO 
buffer. The Gt was eluted with a step of 300 mM NaCl in HYPO. The peak 
fractions were pooled and dialyzed against Gt storage buffer (20 mM Tris pH 7.1, 
2 mM MgSO4, 1 mM DTT, 5 μM GDP, 10% glycerol). The dialyzed product was 
distributed as 200μL aliquots, flash-frozen in liquid N2 and stored at –80°C till 
further use. A concentration of 15 μM Gt, and approximately 7-9mg Gt was 
obtained from 200 retinae using this protocol. 
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2.6 Isolation of  subunits from Holotransducin 
Holotransducin (Gt) stock containing 1 mg of Gt was thawed and diluted 
1:4 in buffer BG1. The sample was applied to a 1mL Blue Sepharose column (GE 
Healthcare) using an Akta Exlorer 10 FLPC system. The column was washed 
with 5 column volumes using buffer BG1 and eluted with a linear gradient of 
buffer BG1 containing 2 M NaCl. The  subunits elute first, followed by the Gt  
subunit. The proteins were identified on the basis of molecular weight using SDS-
PAGE. 
2.7 Site-directed Mutagenesis of Gi1  DNA 
Multiple site-directed mutagenesis reactions were performed on the  
pET-28a(+) Gi1  DNA using the components and parameters specified in the 
QuikChange Multi Site-Directed Mutagenesis Kit (Stratagene, La Jolla, CA). Six 
cysteine residues were chosen to be modified such that four single-cysteine 
containing Gi1  DNA would be produced, each construct containing a Cys at a 
distinct, known position in the sequence- C66, C214, C305, C325. The following 
amino-acid mutations and corresponding DNA primers were used for the 
mutagenesis, with the specific codon change underlined:  
(1) C3S- ggctagcatgggctccacactgagcgctgaggac  
(2) C66A- gctggctactcagaggaagaggctaagcagtacaaagcagtg  
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(3) C214S- cggaagaagtggattcacagctttgaaggcgtgactgcc  
(4) C305S- ggcggctgcgtatatccagagccagtttgaagacctc  
(5) C325A- cacccacttcactgccgccacggatacgaagaatgtg  
(6) C351I- gaataacctaaaagacattggtctcttctaagaattcgagctcc 
100ng of template DNA was mixed with 100ng of each primer. Only anti-
sense primers were added. The 10x reaction buffer, dNTP mix and QuikChange 
Multi Enzyme blend were mixed in de-ionized water was added to make a final 
reaction volume of 25μL. The thermal cycler was programmed to run the 
following temperature and time cycles- (1) 1x 95°C, 1 min; (2) 30x 95°C, 1 min; 
55°C, 1 min; 68°C 13 min; (3) 1x 4°C, overnight. At the end of the PCR reaction, 
the mixture was treated with 1μL of Dpn-I restriction endonuclease and incubated 
at 37°C for 1 h. The Dpn-I treated product was transformed into XL-10 Gold  
E. coli cells according to the manufacturer’s protocol. The cells were plated on an 
LB-agar plate containing 50μg/mL Kanamycin (Kan) and incubated overnight at 
37°C. 8-12 single colonies were picked and re-streaked on a fresh Kan plate and 
sent for sequencing to Genewiz (NJ). The Multi-site QuikChange reaction was 
repeated twice in order to obtain all the desired Cys mutations of the DNA.  
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2.8 Purification of Recombinant Gi proteins 
2.8.1 Hi-yield Heterologous Expression of Gi1  
 BL21(DE3) E. coli cells were transformed with pET28a(+) Gi1  construct 
with C66 as the accessible cysteine (see section 2.6). A single colony was isolated 
from LB-Kan agar plates and introduced into 250mL LB-Kan media, and the 
culture was grown overnight at 37°C with shaking at 250rpm in an incubator. The 
starter culture was diluted 1:100 into 1.6 L of sterilized LB-Kan media, incubated 
at 37°C with shaking at 180rpm and induced with 0.5mM isopropyl- -D-
thiogalactopyranoside (IPTG) at OD600 of 0.5-0.6. The temperature was decreased 
to 30°C and the cells were harvested after for 16 hours. The cell pellet was 
resuspended in storage buffer (40 mM Tris pH 8, 0.3 M NaCl, 2 mM PMSF,  
5 mM 2-mercaptoethanol, 1x Aprotinin and Complete EDTA-free protease 
inhibitor tablets) and stored at –80oC until further use. 
2.8.2 Site-specific Labeling and Purification of C66 Gi1  
E. coli cells were thawed and lysed using a French Press. The lysate was 
centrifuged at 30,000xg, 45 min, 4°C. The supernatant was clarified by passing 
through a 0.45μm syringe filter. 2mL of Ni-Sepharose 6 FF slurry (GE 
Healthcare) equilibrated with 20 mM Tris pH 8, 150 mM NaCl,  
2 mM 2-mercaptoethanol was added to the reaction mixture alongwith  
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20 mM imidazole and incubated for 2-3 h at 4°C. The solution was centrifuged 
and the resin was washed with 10 volumes of buffer G1 containing 20 mM 
imidazole. The resin was transferred to a 2mL eppendorf tube and 0.3 mM  
Alexa-546 maleimide was added in 1mL of slurry. The tube was flushed with Ar, 
wrapped in foil and kept nutating overnight at 4°C. The slurry was transferred to a 
15mL tube and was washed thrice with buffer G1 containing 1 mM DTT. The 
protein was eluted thrice with 300 mM imidazole. The eluate was concentrated to 
approximately 2.5mL using a Centricon centrifugal concentrator with 10 kD 
MWCO. 0.5mL of GST-tagged PreScission protease was added, and the solution 
was dialyzed overnight at 4°C in a 3mL Slide-A-Lyzer dialysis cassette (Pierce) 
against 1000-fold excess of buffer G2. The dialyzed mixture was loaded on a 1mL 
Ni Sepharose 6 FF column (GE Healthcare) and the flowthrough collected, which 
now contained the cleaved, labeled Gi1 . The Ni column flowthrough was applied 
to a GST-Sepharose column and the flowthrough collected. GST-tagged 
PreScission protease was removed from Gi1  at this stage. The GST column 
flowthrough was finally applied to a Superdex 200 10/300 gel-filtration column, 
and the fractions analyzed by SDS-PAGE. Using the above protocol, a 
stoichiometry of 1:10 label to Gi1  was obtained.  
2.8.3 Expression and Purification of N-myristoylated Gi1  
DNA plasmids coding for Gi1  (pQE60-Gi1 ) and yeast N-
myristoyltransferase 1 (NMT1) enzyme (pBB131-NMT1) were a kind gift of Dr. 
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Maurine Linder and were used to express N-myristoylated Gi1  (Duronio, 
Jackson-Machelski et al. 1990). Yeast NMT1 has been shown to co-
translationally myristoylate G-protein -subunits, including Gi1  (Greentree and 
Linder 2004). The two plasmids were incorporated into BL21(DE3) strain of E. 
coli by heat-shock transformation. pQE60-Gi1  had the Amp resistance marker 
and pBB131-NMT1 had the Kan resistance marker; therefore both Ampicilin and 
Kanamycin were used at 50μg/mL each in the LB-agar plates and media. The 
starter cultures and media were prepared similar to Method 2.7.1. The cells were 
grown in LB-Kan-Amp for approx. 3 h at 37°C until the OD600 reached 0.6–0.8. 
The culture was induced with 0.25 mM IPTG and grown at 30°C, 16 h, with 
180rpm shaking. The cells were harvested and stored in 40 mM Tris pH 8,  
1 mM PMSF, 1x protease inhibitor cocktail mix (note: no NaCl was used since 
NaCl would interfere with subsequent purification steps) and frozen in liquid N2. 
The cell pellet was thawed and lysed using a French Press. 0.5 mM 
DNase-I and 5 mM MgSO4 was added and the mixture incubated for 30 min at 
4°C. The solution was centrifuged for 30 min, 30,000xg, 4°C. The supernatant 
was added to 15mL DEAE resin equilibrated with buffer GM1. The slurry was 
incubated for 30 min at 4°C. The slurry was then poured onto a 0.22μm filter 
attached to a Buchner funnel and vacuum line and washed with 100-200mL of 
buffer GM1 under vacuum. The protein was eluted thrice with 40mL buffer GM1 
containing 300 mM NaCl under vacuum and collected. Ammonium sulfate was 
added from a 3.6 M stock to make 1.2 M in the solution containing the DEAE 
eluate. This was loaded on a 25mL Phenyl Sepharose (PS) column (GE 
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Healthcare) pre-equilibrated with buffer GM2 using an Akta Explorer 10 FPLC 
system. The bound proteins were eluted by a decreasing linear gradient of 
ammonium sulfate (buffer GM2) and using buffer GM3 as the elution buffer. The 
peaks were assayed for Gi1  presence by using small aliquots and observing Trp 
fluorescence increase upon addition of aluminium fluoride (Phillips and Cerione 
1988) in a SPEX fluorolog instrument. The final eluted peak is assumed to be 
myristoylated Gi1  based on its higher hydrophobicity and AlF4
- mediated 
increase in Trp fluorescence signal. The peak was applied to a desalting column 
equilibrated with buffer GM1 containg 25 μM GDP. The desalted product was 
applied to a 1mL MonoQ column equilibrated with buffer GM1 and eluted with a 
linear gradient of NaCl. The eluted peaks were assayed for GDP binding by AlF4
- 
and the relevant peak was collected and applied to a Superdex 200 gel-filtration 
column. The peaks eluted from the column were analyzed using SDS-PAGE and 
stored at –80°C until use.  
2.9 Amino Acid Alignment of Zebrafish and Human Apo A-I 
Amino acid sequences of Danio rerio apolipoprotein A-I (NCBI accession 
number: NP_571203) and Homo sapiens apolipoprotein A-I preproprotein (NCBI 
accession number: NP_000030) were downloaded from NCBI in FASTA format 
for analysis.  The first 21 amino acids from the N-terminus of Danio rerio apo A-I 
sequence and the first 24 amino acids from the N-terminus of Homo sapiens apo 
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A-I preproprotein sequence were discarded from the analysis (and subsequent 
constructs) as putative hydrophobic or signal sequences. The sequences were 
aligned using ClustalW (http://www.ebi.ac.uk/clustalw/) and the amino acids 
were color coded to highlight different levels of similarity. 
2.10  Determination of Salt-Bridging Score in Apo A-I 
Salt-bridging analysis, and helical net representations were done 
computationally using the ALIGN and WHEEL software programs (Jones, 
Anantharamaiah et al. 1992; Segrest, Jones et al. 1999) kindly provided to us by 
Jere Segrest from the University of Alabama Medical Center (Birmingham, AL). 
The software was installed, compiled and run on a SGI Octane machine (Silicon 
Graphics Inc., Sunnyvale, CA).  
ALIGN uses an algorithm to sum a weighted score of salt-bridges and 
charge appositions for each helix-helix docking position of the three possible 
interfacial orientations of apo A-I. Salt-bridges and charge appositions are 
determined in the software by taking a helical net representation of the protein 
helix (Jones, Anantharamaiah et al. 1992) arranged as an 11/3 helix monomer 
and inverting and superimposing its L or R interface onto the L or R interface of a 
second monomer beginning with a complete overlap between them. Interactions 
were controlled by distance between residues down the helix axis, by radial 
distance between residues and by radial distance of their average position from 
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the polar-nonpolar interface. Salt-bridges are assigned a score of -1, and like 
charge appositions a score of +1, weighted by a sliding scale reflecting the 
average position of the residue relative to the interface of the polar-nonpolar 
faces. The 2 helical nets were translated relative to each other, one residue at a 
time, in a closed loop fashion. 
Helical net representations were obtained using the HELNET program 
which was part of the WHEEL software suite. This program creates a diagram of 
the  helix seen as a cylinder cut along the center of the polar face and flattened. 
The center of the hydrophobic face (determined by the hydrophobic moment) lies 
in the center of the figure and is oriented to rise out of the page.     
2.11 Cloning of apo A-I DNA Plasmids  
Danio rerio apolipoprotein A-I cDNA was generated by reverse 
transcriptase PCR from 1μg of D. rerio total RNA using the primers 
5’-CAGGCTGATGCCCCGAC-3’ corresponding to N-terminus of the translated 
protein and 5’-TTATGCCTGGATGGCCTTGG-3’ corresponding to the C-
terminus. Restriction sequences for NheI and HindIII were incorporated in the 
primer sequence upstream of the apolipoprotein cDNA sequences. RT-PCR was 
performed using a one-step RT-PCR kit (cMaster RT plus PCR system, 
Eppendorf). The cDNA obtained was cloned into the TOPO cloning vector 
(Invitrogen) and the sequence confirmed. The cDNA was then cut by NheI and 
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HindIII restriction endonucleases and ligated into pET28a(+) vector (Stratagene) 
to give the vector pE28-ZAP1. To incorporate a site-specific cysteine, a single 
Gln residue near the N-terminus was mutated to Cys (Q26C) by site-directed 
mutagenesis of pE28-ZAP1 to yield pE28-ZAP1Q26C.  
Human apo A-I clone was obtained from ATCC (MGC-12499) and cloned 
into a pET16a vector (Stratagene) which was altered to have a N-terminal hexa-
histidine purification tag to give the vector pE16-HAP1.  All nucleotide sequences 
were confirmed by DNA sequencing (Genewiz, South Plainfield, NJ).     
2.12 Purification of His-tagged Apo A-I 
The vector was transformed into BL21(DE3) Rosetta2 strain of E. coli and 
colonies were streak-purified on Kanamycin and Chloramphenicol containing LB-
agar plates. A single colony was grown in 250mL LB media containing 50μg/mL 
of both kanamycin and chloramphenicol overnight at 37oC with shaking and 
called the starter culture. The starter culture was diluted 1:100 into 1.6 L of 
sterilized TB media, incubated at 37oC with shaking at 180rpm and induced with 
1 mM isopropyl- -D-thiogalactopyranoside (IPTG) at OD600 of 0.5–0.6. The cells 
were harvested after for 3-4 hours. The cell pellet was resuspended in storage 
buffer (40 mM Tris pH 8, 0.3 M NaCl, 2 mM PMSF, 5 mM 2-mercaptoethanol, 
1x Aprotinin and Complete EDTA-free protease inhibitor tablets) and stored at  
–80oC until further use. 
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The cell pellet was thawed and the cells disrupted by a French press. Solid 
guanidinum chloride was added to make the 6M concentration in the cell lysate. 
The lysate was incubated at room temperature for 30 minutes, then centrifuged at 
>25,000xg for 1 hour. The supernatant was filtered through a 0.45μm filter and 
loaded onto a Ni-Sepharose 6 FF column (GE Healthcare) pre-equilibrated with 
Buffer T containing 6 M Gn.HCl, 25 mM imidazole at pH 8. The column was 
washed sequentially with 2CV 6 M Gn.HCl containing buffer, 2CV 2 M Gn.HCl 
buffer and finally 5CV of Gn.HCl free Buffer T containing 25 mM imidazole. 
The protein was eluted by an imidazole gradient and the elution followed by 
monitoring OD at 280nm on an Akta Explorer 10 FPLC system. Maximum 
elution occurred at 250–300 mM imidazole. Gel-filtration chromatography was 
performed by pooling the zap1 containing fractions and running on a Superdex 
200 26/60 column (GE Healthcare) and eluting with buffer T with 1 mM TCEP. 
The peaks were assayed for purity by SDS-PAGE. The pure protein was termed 
6xHis-zap1. 
2.13 Site-specific Labeling of 6xHis-zap1Q26C 
A novel on-column approach was used to facilely label the zapIQ26C 
mutant with Alexa-488 maleimide. A 1mL Ni-Sepharose 6 FF column was used 
for labeling the Cys mutant. The fluorophore was made upto 0.2 mM in Buffer T 
containing 2 M Gn.HCl at pH 7.4 from a 22 mM fluorophore stock in DMSO. 
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After the binding zapIQ26C to the column and washing with Buffer T with 6 M 
Gn.HCl at pH 7.4, the fluorophore was introduced with a syringe and the 
flowthrough was passed over the column again. The column was then washed 
with 4CV of Buffer T containing 2 M Gn.HCl and finally 5CV of Gn.HCl free 
buffer containing 25 mM imidazole. The protein was eluted by introducing a 300 
mM imidazole solution in buffer T pH 7.4 by a syringe. The collected fraction 
was subjected to gel-filtration on a Superdex 200 10/30 column and eluted with 
buffer T with 1 mM TCEP. The peaks were assayed for purity and the labeling 
ratio was determined by comparing OD488 and OD280. A 1:1 ratio of Alexa-488 
to zap1 was obtained under the above conditions.  
2.14 Preparation of Labeled Lipids 
POPC was weighed from lyophilized stock and dissolved in 1% sodium 
cholate containing buffer H1 to make a 1% POPC solution. The solution was 
subjected to several freeze cycles in liquid nitrogen followed by vortexing at room 
temperature to get a clear solution. In order to make a labeled lipid stock, 
lissamine rhodamine B-sulfonyl labeled DOPE was dried from a 2mg/mL CHCl3 
stock vial in a glass round bottom flask under Ar gas. The flask was put under 
high vacuum overnight to remove traces of CHCl3. The flask was weighed and the 
amount of dry labeled DOPE was calculated. The dried DOPE was dissolved in 
1% cholate containing buffer H1 to make a 1mg/mL solution. A part of the POPC 
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stock was doped at 1% (w/w) of lissamine rhodamine B sulfonyl and this was 
taken to be the labeled lipid stock. 
2.15 Self-assembly of NABBs and Rhodopsin-NABBs 
The NABB formation with or without rhodopsin incorporated is a self-
assembly process triggered on detergent removal after mixing and incubating the 
NABB components. A molar ratio of 150 POPC : 2 zap1 in 1.5% (w/w) sodium 
cholate and 1.5% OG containing buffer T was taken to form an ‘empty’ NABB.   
For each rhodopsin to be incorporated, 34 POPC were subtracted from the initial 
reaction mixture based on previous reports of area occupied by a rhodopsin 
molecule in a POPC bilayer (Huber, Botelho et al. 2004). Detergent removal was 
accomplished either by dialyzing the samples using Slide-A-Lyzers (Pierce 
Biotechnology, Rockford IL) of appropriate volume against 1000x excess volume 
of detergent free buffer for 36 hours with 2-3 buffer exchanges or by loading the 
reaction mixtures onto pre-equilibrated Extracti Gel D (Pierce Biotechnology, 
Rockford IL) columns typically of 1mL volume, made by loading Extracti Gel D 
slurry into cleaned Sep-Pak columns (Waters). In the case of Extracti Gel D 
reconstitutions, typically 200μL of the detergent containing initial reaction 
mixture was layered on top of the packed 1.5mL resin. The solution was allowed 
to completely enter the column and then eluted by adding 200μL of detergent free 
buffer on top and collecting equal volume of eluate fractions in 1.5mL eppendorf 
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tubes till 1mL of the detergent free buffer has been added to the column. The 
NABBs eluted over 2-3 fractions, as determined by UV-vis spectroscopy. 
Removal of bile-salt based detergents by both dialysis and the rapid extracti gel D 
reconstitution was quantitated by using a 3- -steroid dehydrogenase enzyme 
assay using a total bile-acid assay kit (Diazyme, San Diego, CA) calibrated with 
either cholate or CHAPS and POPC. No significant traces of detergents were 
found after the reconstitutions. Once formed, the rho-NABBs were purified by 
gel-filtration chromatography on a Superose 6 10/30 column using an Akta 
Explorer 10 FPLC system (GE Healthcare, Piscataway, NJ) used within 1-2 days 
for the various assays. All of the above steps were carried out under dim red light 
to keep rhodopsin in its dark state.  
Direct incorporation of rhodopsin from ROS into NABBs was done taking 
a molar stoichiometry of 1 rho per 100 NABBs. Typically, ROS containing  
0.5 μM rhodopsin was taken in a 200 μL aliquot containing 100 μM 6xHis-zap1, 
7.5 mM POPC, 1% DM, Buffer H2 with 2 mM MgCl2 and 1 mM CaCl2. The 
mixture was vortexed, centrifuged and loaded onto pre-equilibrated 1.5 mL 
Extracti Gel D columns, and eluted using detergent free buffer.   
2.16 FRET Measurements between Rhodopsins 
Fluorescence resonance energy transfer (FRET) measurements were made 
in a SPEX Fluorolog tau-3 spectrofluorimeter, equipped with a 450 W Xenon arc-
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lamp and single grating excitation monochromator, set to 0.26nm bandpass and 
the single grating emission monochromator, set to 5nm bandpass. The signal was 
integrated for 2 seconds. Data was recorded for 1 h in 30 seconds intervals to 
account for any changes in the signal due to bleaching of rhodopsin from dark to 
light state by the excitation beam. The excitation shutter was closed in between 
acquisitions to minimize photobleaching. The temperature of the cuvette holder 
was maintained at 20°C by a circulating water bath. The concentration of 
rhodopsin in NABBs or vesicles was kept at 10 nM in the cuvette with 250μL 
buffer H1 for all experiments. The experiment was started after 10 min incubation 
of the rho sample in the cuvette at 20°C. The excitation and emission wavelength 
pairs (in nm) used on the instrument were- (1) Donor (Alexa-546) channel: Ex= 
558, Em= 570; (2) FRET (Alexa-546 to Alexa-647) channel: Ex= 558, Em= 670; 
(3) Acceptor (Alexa-647) channel: Ex= 655, Em= 670. After 1 h of data 
acquisition, dodecyl maltoside (DM) was added from a 20% stock to make 1.5% 
in the cuvette and the solution was mixed. The data acquisition was continued. 
Finally, hydroxylamine was added from a 3.5 M stock to obtain 50mM in the 
cuvette, and the sample bleached using >495nm light and the spectrum was taken 
of the sample in a detergent solubilized, bleached state. The detergent solubilized 
rho reading was considered as the internal control for the respective samples and 
the spectra were normalized using this control. The data right before detergent 
addition was taken for analyzing the FRET index. 
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2.17 Decoration of Rhodopsin in NABBs by Fab Fragments 
Fab fragments from the monoclonal antibody 1D4 were generated by 
proteolytic cleavage of 1D4 by Papain, followed by gel-filtration chromatography 
on a Superdex 200 10/300 column. Purity of the Fab fraction was checked by 
SDS-PAGE and concentration determined by absorbance at 280nm. Fab 
fragments were incubated at equimolar ratio to the rhodopsin in NABBs with 
gentle nutation in the presence of Concanavalin A–Sepaharose beads (Sigma) 
overnight at 4°C. The beads were washed three times with buffer and then the 
Fab-rho-NABB complex was eluted thrice using 100mM -methyl mannoside 
containing elution buffer. The elutions were concentrated using an Amicon-15 
centrifugation filtration device with a 50kD MWCO and the buffer was 
exchanged simultaneously with -methyl mannoside free buffer. The complex 
was then subjected to gel-filtration chromatography over a Superose 6 10/30 
column (GE Healthcare) and the peak fractions were used for EM analysis.   
2.18  Negative-stain Transmission Electron Microscopy 
5μL of freshly prepared NABB sample at a protein concentration of 
approximately 5-10 μg/mL was applied on a 400 mesh carbon coated copper grid 
which had been glow discharged for 10-20 seconds prior to sample application. 
The NABB solution was blotted after 1 minute and an equal volume of 1% uranyl 
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acetate was added immediately. The stain was gently wicked away and the 
staining repeated again. The grids were then imaged under 80keV using a Jeol 
1230 transmission electron microscope equipped with a 1Kx1K CCD camera. 
Images were acquired typically at 1-2 μm underfocus to obtain optimal contrast. 
Nanogold images were acquired at regions of sparse stain and at lower defocus 
(200-500nm) in order to achieve highest density and contrast of the gold clusters 
(Hainfeld, Powell et al. 2002).   
2.19 Circular Dichroism (CD) Spectroscopy and Isothermal 
Titration Calorimetry (ITC)  
CD spectra were recorded at 25°C in an AVIV 202 circular dichroism 
spectropolarimeter. Typically, 22 μL of apo A-I sample at 1.1 mg/mL was 
incubated with 100 μL of POPC at 1.5 mg/mL in the form of Small Unilamellar 
Vesicles formed by sonication. Tris salt buffer (50 mM Tris pH 7.6, 150 mM 
NaCl) was added to a final volume of 400 μL. The sample was vortexed 
immediately and loading into a 0.1 cm path length cuvette and scanned from 
250nm to 190nm with 0.5nm resolution and 1nm bandwidth. The temperature was 
kept constant with a circulating water bath. Raw ellipticity values were converted 
to Molar Residue Ellipticity for comparison of spectra between peptides and 
proteins of varying lengths and concentrations. Ellipticity values in millidegrees 
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millidegrees
# a.acids conc(M ) pathlength(cm) 10
from the AVIV CD software was converted to Molar Residue Ellipticity using the 
equation: 
 
Molar Residue Ellipticity [ ] =   
  
The fraction alpha helicity was calculated from Molar Residue Ellipticity 
at 222nm according the following equation (Wieprecht, Beyermann et al. 2002): 
 
 
[ ] values for the alpha helical and coil parts are derived from:  
[ ]helix = -40000(1 – 2.5/n) + 100t, [ ]coil = 640 – 45t,  
where n is the number of amino acids in the protein (n for zap1 is 266 and 
for h ap1 it is 222) and t is the temperature in °C. 
Isothermal Titration Calorimetry experiments were performed in the VP-
ITC high-sensitivity titration calorimeter (MicroCal, MA). Typically, 20 
consecutive injections of 10 μL aliquots of the apolipoproteins from a stock 
concentration of 60 μM were made into 2 mM POPC Small Unilamellar Vesicles 
in the sample cell. The protein and POPC SUVs were dialyzed against the same 
buffer prior to the experiment and both lipid and protein solutions were degassed 
under vacuum immediately before use. Injections were made at intervals of 15 
min, the duration of each injection was 2 s/μL and a constant stirring speed of 
400rpm was maintained throughout the experiment to ensure proper mixing. The 
fh =
[ ]obs [ ]coil
[ ]helix [ ]coil
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ITC cell temperature was kept at 30oC. Data were analyzed using the Origin 
software provided by MicroCal Inc. 
The experimental data were fitted to a curve corresponding to a Langmuir 
adsorption model of a single class of binding sites to obtain the equilibrium 
association constant (Ka), the enthalpy change ( Ho) and the stoichiometry 
parameter (N, the number of protein molecules bound per lipid molecule). The 
areas under the negative peaks corresponded to the heat released during the 
reaction after the addition of the protein to the SUVs. The values of Ka and Ho 
obtained from curve fitting were used to calculate the standard free energy change 
( Go) and the standard entropy change ( So) for the binding using the equation: 
G° = – RT ln Ka = H° – T S° 
We use a modified standard state with respect to the experimental 
temperature of 30°C. 
2.20 Thermal Stability Assay of Rhodopsin  
Rho-NABBs were formed by dialysis, followed by Ni affinity purification 
in the dark. Aliquots of 1 μM rhodopsin in NABBs or ROS or detergent 
containing buffer H1 were incubated in 0.6mL eppendorf tubes at various 
temperatures in a thermomixer without shaking. After 15 minutes of incubation, 
each aliquot was kept on ice till it was used for a UV-visible scan in a Perkin-
Elmer Lambda 800 UV-visible spectrophotometer at room temperature. The 
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sample was then photobleached under yellow light (>495nm wavelength) for 30 
seconds in the presence of 50 mM hydroxylamine. The intact rhodopsin content 
of the sample was estimated by calculating the difference in absorption intensity 
between the dark and light spectra at 500nm. The absorption was expressed as the 
fraction of absorption of a sample stored at 4oC and plotted as a function of 
temperature. 
2.21 Rhodopsin Meta-II Decay Assay 
Decay of rhodopsin Meta-II state in NABBs was followed by tryptophan 
fluorescence. Rhodopsin concentration was adjusted to 10nM in 10 mM HEPES-
MES-KOH buffer pH 6, 100 mM KCl, 2 mM MgCl2 in a magnetically stirred 
cuvette. The temperature was maintained at 20°C by a circulating water bath 
attached to the cuvette holder. Tryptophan fluorescence was recorded in a SPEX 
Fluorolog tau-3 spectrofluorimeter, equipped with a 450 W Xenon arc-lamp and 
single grating excitation monochromator, set to a center wavelength of 295nm 
with 0.2nm bandpass. A UV-bandpass filter (Hoya U-340, Edmund Optics, Inc., 
Barrington, NJ) was used in addition to the single grating emission 
monochromator, set to 330nm and 10nm bandpass. The signal of the photon-
counting photomultiplier was integrated for 2 seconds. Data was recorded for two 
hours in 30 seconds intervals with the excitation shutter closed in between 
acquisitions to minimize photobleaching, unless stated otherwise. The rhodopsin 
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sample in the cuvette was bleached for 15 sec using a fiber-optics 150 W 
illuminator at full intensity with a yellow filter (model A-200, Dolan-Jenner 
Industries, Inc., Boxborough, MA) after obtaining a dark baseline for 3 minutes.  
The decay of the photolyzed state was followed for 2 hours. 
2.22 Regeneration of Opsin in NABBs 
Opsin-NABBs were generated by photobleaching 1 μ  of 1 rho-NABB in 
buffer H2 pH 6 for 1 minute and incubating the photobleached sample at room 
temperature for more than 2 hours. A UV-vis scan was done every 10 minutes to 
ensure the lack of any significant absorbance at 480-550nm region. The sample 
was compared with a control containing 50 mM NH2OH. 11-cis-retinal was 
solubilized from a 2 mM ethanolic stock upto 100 μM in approximately 1μM 
empty NABBs and vortexed vigorously to ensure proper mixing. Concentration of 
11-cis-retinal was determined by its absorption peak at 378nm and using a molar 
extinction coefficient of 24940 M-1 cm-1. Under dim light, 11-cis-retinal loaded 
NABBs were gently added by a microcapillary pipette tip to a final concentration 
of 0.5 μM 11-cis-retinal to a stirred microcuvette containing 700μL of 0.5 μM 
opsin-NABBs. Absorbance was monitored at 520nm, with a slit width of 0.5nm, 
integration time of 1 sec and time interval of 3 seconds. After saturation of the 
absorbance signal, 50 mM of NH2OH was gently added from a 3.5 M NH2OH 
stock. Finally, the sample was bleached using hi yellow light.     
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2.23 Transducin Activation Assay using Intrinsic Trp 
Fluorescence 
1 rho-NABB sample was purified by 1D4 affinity purification of the 
dialysis product of a starting ratio of 0.1 rho/NABB to remove ‘empty’ NABBs 
from interfering in the assay. Following 1D4 affinity, both 1 rho-NABB and 2 
rho-NABB samples were subjected to FPLC purification in the dark. Activation 
of holotransducin by rhodopsin incorporated in NABBs was analyzed by the 
tryptophan fluorescence assay (Fahmy and Sakmar 1993). Typically, 10 nM of 
rhodopsin-NABBs was added to 100 nM holotransducin in 10 mM HEPES-MES-
KOH buffer pH6.9, 100 mM KCl, 2 mM MgCl2 in a continuously stirred cuvette 
thermostatted at 10°C in a SPEX Fluorolog-II spectrofluorimeter.  The sample 
was excited at 300nm with 2nm slit width and emission was recorded at 340nm 
with a 12nm slit width.  GTP- S was added to a final concentration of 5 M in the 
cuvette. The cuvette was then illuminated by 543nm light from a HeNe laser and 
the spectra was collected under constant illumination to photoactivate rhodopsin.  
The curve obtained was analyzed by fitting an exponential corresponding to a 
pseudo-first order kinetics.  
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2.24 Isolation of Heterologously Expressed CCR5 Receptor and 
Incorporation in NABBs 
HEK-293 cells stably expressing CCR5 were harvested and the cell pellet 
stored in PBS buffer containing protease inhibitors at –80°C. Cell pellets 
corresponding to 2 x 10 cm plates were thawed on ice and lysed using 500mL of 
buffer N1. The solution was sonicated using a probe-tip sonicator for 6 x 1 s 
pulses with 10 s cooling on ice. The tube was then incubated at 4°C with gentle 
mixing for 30 min. The tube was centrifuged at 20,000xg for 20 min at 4°C. The 
supernatant was collected and applied to 50mL of 1D4-sepharose slurry loaded 
with 2mg/mL of 1D4 and the mixture incubated at 4°C with gentle mixing for 30 
min. The resin was centrifuged and washed with 500mL of buffer P2. The 1D4 
bound protein was eluted by adding 50mL of buffer P2 containing 1D5-
nonapeptide. Zap1 was added to the eluate at a final concentration of 80 μM. The 
mixture was vortexed, incubated on ice for 30 min and applied to a pre-
equilibrated 500mL Extracti Gel–D column at 4°C. Elution was carried out under 
gravity flow by addition of detergent free buffer to the column and collecting 
50mL fractions. The fractions were analyzed for protein elution by monitoring 
absorbance at 280nm.  
The protein containing fractions were pooled and applied to a Superose 6 
PC 3.2/30 gel-filtration column. The eluted peaks corresponding to the NABB 
elution were applied to 50μL of 1D4-sepharose. The resin was washed with buffer 
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P2 and eluted with 1D5 containing buffer P2. Aliquots from different stages of 
this protocol were used to assay for CCR5 using ELISA or western blots.   
2.25 Sandwich ELISA to detect GPCR in NABBs 
 The primary (capture) antibody was diluted to 1μg/mL in 1xPBS pH 7.2 
and 100μL was added to each well of the microplate (Costar clear-bottom, black 
96-well). The plate was kept overnight at 4°C. The wells were washed twice with 
PBS containing 0.05% Tween-20. The wells were washed once with PBS and 
200μL of 10mg/mL (1%) fatty-acid free BSA in PBS. The plate was either 
incubated at room temperature for 2 h or overnight at 4°C. The GPCR-NABBs 
were added to the respective wells in a final volume of 100μL. The GPCR-NABB 
was diluted in PBS containing 1mg/mL (0.1%) BSA. The microplate was 
incubated at 4°C overnight to ensure complete binding of epitope on the GPCR-
NABB to the capture antibody. The analyte was then washed out thrice with 0.1% 
BSA-PBS using 200μL per wash. HRP-conjugated secondary (detection) 
antibody was added at 0.5-1.0μg/mL in each well (depending on the antibody 
affinity to the second epitope on the GPCR-NABB). The plate was incubated at 
room temperature for 2 h. The wells were washed 3-4 times with 0.1% BSA-PBS. 
A fresh working solution of Amplex Red and H2O2 was prepared from DMSO 
stock of Amplex Red and 3% H2O2 according to the manufacturer recommended 
protocol (Invitrogen, CA). 50μL of the Amplex Red working solution was 
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dispensed in each well and the plate was incubated for 30 min at room 
temperature, protected from light. The fluorescence in the wells were measured 
using a Cytofluor-II spectrofluorimeter with excitation at 530nm and emission at 
590nm. 
2.26 High-throughput G-protein activation assay 
A black, C-bottom 96-well plate was used for the high-throughput G-
protein activation assay. 25μL of purified G protein or its subunits were added to 
the microplate wells from 150 mM protein stock. The proteins added were either 
Gi1  subunit, Gi1  with transducin  subunits, or holotransducin (Gt), with 25μL 
of buffer G1 without GDP. CCR5-NABBs was incubated with 50 nM RANTES 
on ice for 30 min. 100μL of CCR5-NABB solution with and without RANTES 
were added to the respective wells and the microplate incubated at room 
temperature for 15 min. 60μL of BODIPY-FL-GTP S was added from a 1 μM 
stock to all wells using a multi-channel pipettor. The plate was shaken for 30 sec, 
covered and incubated at room temperature for 5 min. The fluorescence in the 
wells was recorded using a Cytofluor II microplate reader with excitation 
wavelength= 485nm and 20nm bandpass, emission wavelength= 530nm and 
25nm bandpass. The gain was set to 95 and 15 reads were integrated for each 
well. The fluorescence values from the wells containing BODIPY-FL-GTP S and 
no G protein was subtracted from the rest of the data as background. The 
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fluorescence values from wells containing the CCR5-NABBs with no RANTES 
was subtracted from RANTES containing wells to give the RANTES specific 
response.   
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3.0   
Formation and Characterization of  
Nanoscale Apolipoprotein Bound Bilayer (NABB) 
Particles by Zebrafish Apo A-I (Zap1) 
3.1 Introduction 
Apolipoproteins have been classified as ‘protein detergents’ (Segrest, 
Garber et al. 1994) that stabilize the size and structure of lipoprotein particles. 
The main function of apolipoproteins is considered to be lipid transport in the 
intravascular and extravascular regions in all organisms where these 
apolipoproteins are present (Li, Tanimura et al. 1988). Apo A-I is the main 
protein in high density lipoprotein (HDL) particles (density 1.06-1.21 g/mL) and 
involved in reverse cholesterol transport in the body. The structure and 
mechanism of action of human apo A-I has been a topic of intense investigation 
since human apo A-I has been implicated to play a protective role against 
 
Material in this chapter has been previously published in: Banerjee S, Huber T, Sakmar TP. (2008) 
Rapid Incorporation of Functional Rhodopsin into Nanoscale Apolipoprotein Bound Bilayer 
(NABB) Particles. J. Mol. Biol. 377(4): 1067-81.  
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coronary heart disease in humans (Bhat, Sorci-Thomas et al. 2005). Human apo 
A-I is a 243 amino acid protein that contains a putative globular N-terminal 
domain (residues 1-43) and a lipid-binding C-terminal domain (residues 44-243) 
(Segrest, Jones et al. 1992). Analysis of the human apo A-I gene and protein 
sequence first gave the idea that apo A-I contains eight 22-mer and two 11-mer 
tandem amino acid sequence repeats punctuated by prolines, and encoded by exon 
4 of the apo A-I gene (McLachlan 1977; Karathanasis, Zannis et al. 1983).  
The 4Å solution X-ray crystal structure of human apo A-I (44-243 amino 
acids) (Borhani, Rogers et al. 1997) showed an almost continuous -helix 
punctuated by small or large proline induced kinks (Fig. 1-6 A). Apo A-I appears 
as four monomers in a unit cell, forming two antiparallel dimers. The dimers form 
central helix 5-5 and C-terminal helix 10-10 overlaps. A detailed molecular 
‘double-belt’ model of apo A-I was subsequently proposed by considering lipid 
bilayer constraints on the arrangement of the protein (Segrest, Jones et al. 1999). 
The double-belt orientation of apo A-I (Fig. 1-7) has since been generally 
accepted and has proved consistent with recent analyses of HDL structure (Li, 
Lyles et al. 2000; Li, Chen et al. 2004; Silva, Hilliard et al. 2005; Li, Kijac et al. 
2006).  
The common lipid-associating structural motif in all exchangeable 
apolipoproteins is the amphipathic -helix and any differences in lipid-binding 
properties of the apolipoproteins of similar number of amino acids can therefore 
be extrapolated to differences in the properties of the amino acids constituting the 
-helices as well as the relative arrangement of the -helices.  
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Formation and structural stability of HDL particles is critically dependent on the 
following parameters (Catte, Patterson et al. 2006): 
1. Amphiphatic properties of apo A-I helices. 
2. Flat planar discoidal (bilayer) geometry of HDL particles. 
3. Helical curvature of the apolipoprotein dictated by the low dielectric 
constant of the lipid tails and high dielectric constant of the solvent. 
4. Critical role of salt-bridges between the apolipoprotein helices to form 
a ‘dimer’ of apolipoprotein around the circumference of the bilayer 
disc. 
 
The salt-bridging pattern between pairs of identical apo A-I helices from 
different species has been estimated by computationally docking one molecule of 
apo A-I over the second one in a certain interfacial orientation (Segrest, Jones et 
al. 1999). Strikingly, the general pattern of inter-helical salt-bridging in apo A-I is 
conserved in birds, mammals and fish. The salt-bridging pattern for zebrafish apo 
A-I shows a regular appearance of minima throughout the length of the helix, 
compared with human apo A-I where the minima are less regular and often 
compensated by charge appositions (Fig. 1-7 E). We hypothesized that this 
difference in salt-bridging pattern between zebrafish and human apo A-I may 
indicate that zebrafish apo A-I may adopt a higher number of stable inter-helical 
orientations compared with human apo A-I – a property that may enable us to 
utilize zebrafish apo A-I for forming discoidal lipoprotein particles rapidly and 
with stability even upon dilution. Although there have been scarce reports on the 
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properties of fish apo A-I, it has mainly been implicated in a direct functional role 
of maintaining trans-epithelial resistance in rainbow trout gills (Smith, Wood et 
al. 2005). 
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Figure 3-1. Sequence Comparison of Zebrafish apo A-I with Human 
apo A-I  
 
Amino acid sequence comparison of mature zebrafish 
apolipoprotein A-I with human apolipoprotein A-I. (Top) Amino acid 
sequence alignment of D. rerio (Z) apo A-I, aligned with H. sapiens (H) 
apo A-I was performed using ClustalW 1.8 program 
(http://www.ebi.ac.uk/clustalw/). Invariant amino acid residues are shown 
in red and chemically similar residues are shown in green. Residue on 
zebrafish apo A-I that was chosen for a single point mutation to Cys in 
zap1Q26C is marked with *. N-terminal deletion for human 1–43 apo A-
I is also marked. (Bottom) Domain structure of hexa-histidine tagged 
zebrafish apo A-I construct (zap1) and human 1–43 apo A-I (h ap1) 
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3.2.1 Amino Acid Sequence Comparison between Human Apo A-I and 
Zebrafish Apo A-I 
In a discoidal High Density Lipoprotein (HDL) particle, two molecules of 
human apo A-I are hypothesized to form a ‘double-belt’ around the discoidal lipid 
particle that run circumferentially anti-parallel to each other (Segrest, Jones et al. 
1999). The amphipathic helices are punctuated by periodic proline residues, 
which are believed to kink the helices to facilitate forming of the circumferential 
belt with the helix axis perpendicular to the lipid acyl chains. An apolipoprotein 
that binds to lipids in a manner similar to human apo A-I to form discoidal lipid 
particles would share a similar distribution of amino acids. To test the 
conservation of amino acid patterns between the two apolipoproteins, an amino 
acid sequence alignment was performed (Fig. 3-1). Invariant proline residues 
occur every 22 or 11 amino acids, suggesting that the length of zebrafish apo A-I 
may be divided into tandem 22/11-mer helices which interact with the lipid side 
chains and are punctuated by proline ‘hinges’, similar to the hypothesized lipid-
binding mechanism of human apo A-I. The alignment also shows a general 
conservation of the chemical type of the amino acid residue in zebrafish apo A-I 
at the corresponding positions of the human apo A-I. The sequence similarity 
points to a similar lipid binding mechanism and amphipathicity of zebrafish apo 
A-I compared with human apo A-I. Hydropathy analysis shows the C-terminal 
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residues may not be as important for lipid binding in zebrafish apo A-I compared 
with human apo A-I. N-terminal tails of both zebrafish and human apo A-I show a 
conserved pattern of high hydrophobicity, indicating a possible role of the N-
terminal residues of zebrafish apo A-I in lipid binding. 
Human apo A-I is known to form various HDL subclasses distinguished 
on the basis of the diameters of the discoidal complexes (Jonas, Kezdy et al. 
1989; Jonas, Steinmetz et al. 1993). The amino acid sequence of apo A-I is 
considered to be the primary determinant of HDL subclass formation. Most 
species, for example mice, generate monodisperse HDL particles, whereas 
primates and humans make distinct HDL subclasses. The two major subclasses 
being HDL2 (larger and more buoyant) and HDL3 (smaller) (Reschly, Sorci-
Thomas et al. 2002). A major difference between the amino acid sequences of apo 
A-I in humans and non-primates is the lack of a Pro residue between putative 
helices 7 and 8 in human apo A-I (Frank and Marcel 2000). A report comparing 
the effects of replacing the non-proline containing sequence between helices 7 
and 8 in human apo A-I with a proline containing sequence led to preferential 
formation of HDL2 (smaller discs) by the chimeric human apo A-I (Carnemolla, 
Ren et al. 2008).  Notably, zebrafish apo A-I contains a proline at position 186 
(Fig. 3-1) which is the region between putative helices 7 and 8, with no 
corresponding proline at the same position in human apo A-I. The presence of 
Pro186 in zebrafish apo A-I may be a possible reason for the monodisperse nature 
of discoidal liproprotein particles formed by zebrafish apo A-I NABBs, compared 
with human apo A-I. 
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3.2.2 Salt Bridging between Apo A-I Helices 
We analyzed the distribution of amino acids on zebrafish apo A-I using 
the HELNET program (Fig. 3-2 A, B). This program creates a diagram of the  
helix seen as a cylinder cut along the center of the polar face and flattened. A 
continuous  helical net display of the putative tandem helices formed by the C-
terminal 200 amino acids was plotted using either a pitch of 3.6 residues (18/5) 
per turn (Fig. 3-2 A) , or a ‘tighter’ pitch of 3.6667 residues (11/3)  per turn (Fig. 
3-2 B). As seen in the amino-acid distribution in the 18/5 helix, if the helix were 
closed as a cylinder, the hydrophobic face would twist around the resulting torus, 
instead of lying at the center of the helix as required by the double-belt model 
(Segrest, Jones et al. 1999). If the amino-acids are arranged according to a 11/3 
helix, a comparatively straight (planar) hydrophobic face is formed. Further, we 
saw a marked separation of positively charged residues and negatively charged 
residues on respective edges of the helical net in the 11/3 helix (Fig. 3-2 B). Such 
a separation may be critical to the formation of effective and long-range salt-
bridges between two anti-parallel arrangements of the zap1 helices in a discoidal 
lipoprotein particle. However, the HELNET program does not account for the 
special role of proline residues in the sequence, the presence of which may break 
the pattern of amino-acids. 
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Figure 3-2. Helical Net Analysis and Salt Bridging Scores between 
Zebrafish Apo A-I Helices 
 
(A) Arrangement of hydrophobic (black), positively charged (blue) 
and negatively charged (red) amino acids in zebrafish apo A-I (Zap1) 
when Zap1 adopts a regular  18/5 helix. Zap1 was plotted with an 
idealized pitch of 3.6 residues/turn using the HELNET program. (B) 
HELNET plot of zap1 with the amino acid residues arranged in an 
11/3 helix with 3.6667 resuidues per turn of the helix. A difference in 
the distribution of hydrophobic and charged amino acids can be seen in 
these two types of helical arrangements. Clustering of charged amino 
acids towards the edges of the helix and hydrophobic amino acids towards 
the center is observed in the 11/3 helix configuration (C) Weighted salt 
bridging scores of two zap1 molecules arranged in an –11/3 helix. Salt 
bridging scores using all possible ring pair interfaces between the 2 zap1 
molecules are shown. Antiparallel arrangements- left to left (LL) and right 
to right (RR). Parallel arrangements- left to right (LR) and right to left 
(RL). For each residue step (x axis) representing one docking position, 
each weighted score is shown (y axis). The weighted number of salt 
bridges and like charge appositions were calculated for each docking 
position using the ALIGN program. The net salt bridging score is 
favorable only in the LL (antiparallel) arrangement of the helices. 
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Figure 3-2. Helical Net Analysis and Salt Bridging Scores between 
Zebrafish Apo A-I Helices 
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Salt bridging between the apo A-I helices is reported to play a crucial role 
in determining the specificity of the helix-helix registry in a HDL particle 
(Segrest, Jones et al. 1999; Klon, Jones et al. 2000; Klon, Segrest et al. 2002). 
Molecular dynamics simulations of model peptides with POPC bilayer has shown 
that interhelical energetics is dominated by salt bridges (Sheldahl and Harvey 
1999). We used the ALIGN program (Segrest, Jones et al. 1999) to compare the 
weighted salt-bridging score between helices in mature zebrafish apo A-I and 
human apo A-I proteins (Fig. 3-2). A lower score indicates more favorable salt 
bridging (attractive forces) between helices at that position. We noticed that both 
apolipoproteins have a net favorable salt bridging score when the two apo A-I 
helices are in antiparallel orientation with respect to each other (Fig. 3-2). We 
also noticed that zebrafish apo A-I exhibited a more regular pattern of negative 
peaks (favorable salt bridges) in the score throughout the length of its helix 
compared with human apo A-I. This may point to a mechanism in zebrafish apo 
A-I where multiple possible helical registries are possible, as opposed to one 
particular more favorable registry as with human apo A-I. It is likely that by not 
constraining the relative orientations (helix registers) of the apo A-I helices, 
zebrafish apo A-I may be able to form discoidal lipid particles rapidly. The 
particles formed by zebrafish apo A-I may also be more resistant to dilution 
compared with human apo A-I since the zebrafish apo A-I helices will be able to 
dock in multiple orientations in an equilibrium between lipid-bound and lipid-free 
states at high dilutions. 
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Figure 3-3. Vector Map and Purification of Zebrafish Apo A-I 
 
(A) Vector map showing the salient features of the pE28-ZAP1 
DNA derived from the pET28a(+) vector. Restriction endonuclease sites 
utilized for preparing and checking the vector are shown. (B) Ni-affinity 
purification of zap1 was performed and His-tagged protein eluted with an 
imidazole gradient. (C) Gel-filtration chromatography using a Superdex 
200 26/60 column showed that the zap1 formed tetramers in the gel-
filtration buffer. The tetramer peak was pooled to obtain pure zap1 (>95%) 
as shown in the inset. The presence of truncated protein (trunc.) 
contaminates the monomer peak, but not the tetramer. The inset shows 
Coomassie Blue stained fractions of lysate and the tetramer peak from the 
Superdex 200 column. The rightmost lane shows fluorescent detection of 
Alexa-488 modified zap1Q26C protein cloned and labeled as outlined in 










3.2.3 Purification and Site-specific Fluorescent Labeling of Zebrafish 
apolipoprotein A-I (zap1)  
We used reverse-transcriptase PCR to generate zebrafish apo A-I cDNA, 
which was inserted in a high-fidelity protein expression vector pET28a(+) 
(Novagen, San Diego, CA). The resulting vector- pE28ZAP1 (Fig. 3-3 A) had the 
zap1 sequence transcribed by the T7 RNA polymerase, under control of the lacI 
promoter which was de-repressed by the addition of isopropyl- -D-
thiogalactoside (IPTG) (Glick and Pasternak 1994). The vector carried a 
Kanamycin resistance marker which was used for selecting colonies containing 
the vector on a LB-Agar plate (or other media) supplemented with 50μg/mL 
Kanamycin. The vector also carried a hexa-histidine coding region upstream of 
the zap1 sequence, followed by a PreScission protease cleavage site. We also 
prepared a bacterial expression vector coding for human apo A-I using pET16b 
vector (Novagen). Human apo A-I cDNA was obtained from ATCC, excised and 
inserted into pET16b vector using appropriate restriction endonucleases. The 
resulting vector- pE16HAP1 contained the human apo A-I sequence transcribed 
by T7 RNA polymerase, under control of the lacI promoter. The vector carried an 
Ampicillin resistance marker, and a hexa-histidine coding sequence upstream of 
the hap1 sequence, followed by a Factor Xa protease cleavage site. Subsequent 
site-directed mutagenesis reactions were performed on these DNA constructs. 
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After E. coli expression and cell lysis, the hexa-histidine tag was used to 
affinity purify zap1 on a Ni column, using an imidazole gradient (Fig. 3-3 B). 
Gel-filtration chromatography of Ni-affinity purified hexa-histidine tagged 
zebrafish apo A-I (zap1) yielded protein at greater than 95% purity as judged by 
densitometry of the SDS-PAGE lane (Fig. 3-3 C). The tendency of apo A-I to 
form higher order oligomers was exploited in the gel-filtration step; the highest 
purity of zap1 on SDS-PAGE was the fraction corresponding to the size of a zap1 
tetramer. A large amount of protein in the subsequent fractions was truncated as 
judged by SDS-PAGE. The truncation may either be due to aborted protein 
synthesis of zap1 in E.coli or proteolysis of the full-length protein in the bacteria. 
The ability of the truncated products to be co-purified on the Ni-affinity column 
alongwith the full-length zap1 under denaturating conditions indicates that the 
truncation occurred  from the C-terminus (the hexa-histidine tag is present on the 
N-terminus).  
A putative solvent-accessible glutamine residue near the N-terminus was 
chosen for point mutation to cysteine (shown by * in Fig. 3-1) to enable coupling 
to maleimide-linked fluorophores. For labeling the Cys mutant, a protocol 
reported for an on-column labeling procedure (Bergendahl, Anthony et al. 2002) 
was followed with slight modifications.  
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Figure 3-4. Native Polyacrylamide Gradient Gel Electrophoresis of 
NABBs 
 
NABBs were prepared using LRB-DOPE doped POPC and zap1 in 75 
POPC : 1 zap1 ratio. (Top panel) Gray curve— Densitometric scan of the 
fluorescence distribution in the gel lane after detection of rhodamine 
fluorescence (corresponding to doped lipids). Black curve— 
Densitometric scan of protein distribution made after Coomassie Blue 
staining of the same lane. The Stokes’ diameter was calculated from the 
migration of standard proteins with known hydrodynamic radii in adjacent 
lanes: Thyroglobulin 17nm, Ferritin 12.2nm, Catalase 9.2nm, Bovine 
Serum Albumin 7.1nm. (Bottom panel) Lane showing protein distribution 
detected by Coomassie blue staining and lipid distribution detected by 
rhodamine fluorescence of the same lane. The gel was run to equilibrium 













3.2.4 Characterization of Lipoprotein Particles formed by Zebrafish Apo 
A-I 
The products of the interaction of zebrafish apo A-I (zap1) and POPC 
upon detergent removal were characterized by native polyacrylamide gradient gel 
electrophoresis, and gel-filtration chromatography followed by electron 
microscopy imaging. The native gradient gels were analyzed at equilibrium by 
running the gels for 24 h at 16°C (Fig. 3-4). Under these conditions, the particles 
migrate due to a combined influence of the net charge on the particle (primarily 
due to zap1, since POPC is a zwitterionic lipid) and sieving effects of the cross-
linked agarose gel.   
To observe the effect of different POPC ratios on the hydrodynamic radius 
of NABBs, different POPC to zap1 ratios were used to reconstitute NABBs by 
extensive dialysis to remove detergent. The NABB samples were then analyzed 
by gel-filtration chromatography on a calibrated Superose 6 10/30 column. Three 
POPC to zap1 ratios are shown in Fig. 3-5. We detected evidence of three particle 
populations with maximal Stokes diameters of 10nm, 11.6nm, and 12.5nm in 
addition to a void volume fraction containing vesicles. Upon increasing the 
POPC:zap1 ratio to 100:1, we also detect a significant population of 17nm 
diameter discs.  
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Figure 3-5. Gel-filtration, EM imaging and Histogram of Diameters of 
Lipoprotein Particles formed by zebrafish apo A-I   
 
 
(A) Formation of discoidal lipoprotein particles by zebrafish apo 
A-I with POPC. Size-exclusion chromatography of lipoprotein particles 
formed between zebrafish apo A-I and POPC upon detergent removal by 
dialysis at different molar ratios of POPC to zap1— 25:1, 75:1, and 200:1. 
The Stokes’ Radii determined by calibration of the Superose 6 10/30 
column were: a-12.5nm, b-11.6nm, c-10.0nm, v-void volume. 
Representative negative stain EM images of the main peak fractions 
(shaded area) are shown as insets. The scale bar in all cases is 50nm. (B) 
A histogram of the size distribution of particles formed by zebrafish apo 
A-I and POPC at a POPC to zap1 ratio of 75:1 from EM imaging. 
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Figure 3-5. Gel-filtration, EM imaging and Histogram of Diameters of 





In comparison, Rogers et al. (Rogers, Brouillette et al. 1997) have 
reported that human apo A-I forms particles of diameters 8.5nm (78%), 12.0nm 
(21%) and 15.5nm (1%) with POPC, whereas human 1-43 apo A-I gives 
particles of diameters 8.5nm (47%), 12.5nm (18%) and 16.5nm (35%). These 
results are consistent with our experience. Compared with zap1 and POPC which 
tends to form a homogeneous disc population, h ap1 forms discs with a broad 
and heterogeneous size distribution. A smaller diameter of NABBs in very low 
POPC: zap1 ratios could either be explained by correspondingly smaller number 
of amino acids contacting the lipid which is limiting, resulting in a ‘buckling’ of 
the planar disc structure (Catte, Patterson et al. 2006). When the lipid: zap1 ratio 
is in large excess of the optimized ratio for disc formation, the dominant product 
is vesicles. We confirmed discoidal morphology of the NABBs by negative stain 
EM and observed typical rouleaux (stack) formations of NABBs as well as well-
defined separated NABBs with average diameters of 10–13nm and thickness of 
about 5nm as the main structures when the molar ratio was 75 POPC:zap1. 
Sizing of the particles was done from the images using the magnification 
parameters of the image in the ImageJ software image analysis program. 
Measurements of diameter were done on free-standing particles with a circular 
profile and plotted as a histogram (Fig. 3-5 B).    
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Figure 3-6. Circular Dichroism (CD) and Isothermal Titration 
Calorimetry (ITC) of zap1 Interaction with POPC Small Unilamellar 
Vesicles (SUVs) 
 
(A) Far UV CD spectra are shown for 6 His zebrafish apo A-I (zap1) in 
buffer (empty circles) or in buffer containing POPC SUVs (filled circles). 
Spectra are also shown for 6 His human 1–43 apo A-I (h ap1) in buffer 
(empty triangles) or in buffer with POPC small unilamellar vesicles (filled 
triangles). (B) ITC time trace of zap1 injected into dispersion of POPC 
SUVs. The heat of injection (lower panel) is plotted by integrating the area 
under each injection peak (upper panel). The last few injections were 
taken as the heat of dilution and subtracted from the entire run.  
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Figure 3-6. Circular Dichroism (CD) and Isothermal Titration 









Table 1. Interaction of Apo A-I with POPC Vesicles 
CD parameters for zap1 and h ap1* 
Sample [ ]222 10
3
 fh Residues 
zap1 in buffer 14.4±0.3 0.38 102 
zap1 + POPC 20.7±0.3 0.55 147 
h ap1 in buffer 12.9±0.4 0.33 76 
h ap1 + POPC 17.0±0.1 0.45 101 




















4.09±0.80 1.91±0.05 59.7±1.1 11.6 48.0 
h ap1  
+ POPC 
0.55±0.95 1.70±0.14 98.5±1.1 10.4 88.1 
 
* Experiments were performed at 25°C. 
** Experiments were performed at 30°C. Each value represents the average of at 
least three experiments. The H° and S° values are per mole of apo A-I. 
a G° = RT ln(55.5M Ka )  (Rogers, Brouillette et al. 1997; Seelig 2004) 
bT S° = H° G° 
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3.2.5 Interaction of Zebrafish Apo A-I with Lipid Vesicles 
We compared the lipid-mediated helicity change and thermodynamics of 
zap1 with that of an N-terminal 1–43 amino acid truncated human apolipoprotein 
A-I (h ap1) construct that has been hypothesized to form a model antiparallel 
double-belt orientation around a HDL particle (Borhani, Rogers et al. 1997) and 
has been used to incorporate membrane proteins (Bayburt, Grinkova et al. 2002). 
It is noteworthy that apo A-I interaction with POPC SUVs does not form NABBs. 
However, the interaction of lipid-free apo A-I with the phospholipid membrane of 
the SUV induces -helical structure (White and Wimley 1999; Seelig 2004), 
which may be measured using circular dichroism (CD) spectroscopy and 
isothermal titration caloriemetry (ITC). The conditions in our CD experiments are 
similar to those in Arnulphi et al. (Arnulphi, Jin et al. 2004), who reported 
interaction of mature human apo A-I with POPC SUVs. The data for Molar 
Residue Ellipticity (MRE) obtained by them for human apo A-I are similar to our 
data using zap1. Surprisingly, the fractional helicity (fh) obtained by us for zap1 
(Table 1) using the empirical relation of Scholtz et al. (Scholtz, Hong et al. 1991) 
are 20-25% lower than what Arnulphi et al. report for human apo A-I. However, 
based on the similarity of the two proteins and experimental conditions, the fh 
values of human apo A-I and zap1 should be identical since the MRE values are 
virtually identical. Rogers et al. (Rogers, Brouillette et al. 1997) and Li et al. (Li, 
Chen et al. 2004) have reported comparisons of human apo A-I with N-terminal 
1-43 truncated human apo A-I (similar to h ap1). The MRE values reported in 
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these papers are systematically higher than those of either Arnulphi et al. or ours. 
Interestingly, these two papers seemingly contradict each other in the extent of 
helicity of human apo A-I and h ap1. The discrepancy between our data and the 
published data highlighted above are likely due to an instrumental artifact of the 
CD spectrometer used in these studies that appears to give systematically lower 
ellipticity values, not unusual for CD instruments (Konno, Meguro et al. 1975). 
Despite the difficulties in comparing data from different groups, our data in Table 
1 clearly indicate that zap1 undergoes a larger increase in helicity compared with 
h ap1 upon interacting with POPC SUVs. Apparently, nearly twice as many 
amino acid residues become -helical in zap1 compared with h ap1 upon 
interaction with POPC SUVs.  
Comparing the affinity of apo A-I to POPC SUVs from our data (Table 1) 
and from Arnulphi et al. (Arnulphi, Jin et al. 2004), we found that the association 
constant (Ka) for zap1 is more than 7-fold greater than that of h ap1, but 
approximately equal to that of human apo A-I. On the other hand, the 
stoichiometry of binding of zap1 and h ap1 to POPC are similar but 3-times 
higher than reported for human apo A-I. The reaction enthalphy ( °) shows that 
zap1 has only about 60% of the favorable reaction enthalpy compared with h ap1 
and human apo A-I. It is interesting to note that while zap1 shows significantly 
reduced values of enthalpic and entropic contributions to the free energy change 
compared with h ap1, enthalpy-entropy compensation results in similar G° 
values for both apolipoproteins. In both cases the interaction with POPC is 
enthalpy driven.  
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3.3 Discussion 
3.3.1 Biological Role of Apo A-I 
The main role of apolipoprotein A-I in most organisms where it is found is 
in the reverse cholesterol transport (RCT) pathway. In RCT, lipids and free and 
esterfied cholesterol are carried from peripheral tissues to the liver by High 
Density Lipoprotein (HDL) particles. These HDL particles are formed by lipids 
and apo A-I, with 1–4 apo A-I molecules per HDL (Fielding P.E. and C.J. 2002), 
together with other apolipoproteins that specify the metabolism and delivery of 
these lipids. Newly formed HDL have high density primarily due to apo A-I and 
little lipid. Their density decreases as they take up lipid in the circulation. The 
classical subfractions of HDL are– HDL3 (density 1.12-1.219 g/mL), HDL2 
(1.063-1.12 g/mL), HDL1 (density < 1.063 g/mL). 
In humans, apo A-I is synthesized by the liver and small intestine. HDL-
containing apo A-I is formed in the extracellular space. Lipid-poor apo A-I 
associates with cell-derived phospholipids and cholesterol. The association of apo 
A-I and phospholipids is thermodynamically favorable; phospholipid-free mature 
human apo A-I has not been detected in biological fluids.  
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3.3.2 Evolution of Apo A-I 
Apolipoproteins are lipid binding proteins comprising of amphipathic 
helices. Apo A-I is conserved throughout evolution from insects (called 
apolipophorins) to humans with its primary function being lipid binding and 
transport. The majority of the structural and functional aspects of apo A-I had 
been elucidated due to extensive studies on human apo A-I. Apo A-I is 
synthesized in-vivo in the liver and small intestine as a 267 amino acid pre-
proapoA-I. The proapoA-I is secreted into the plasma after an intracellular 
peptidase cleaves the 18 amino acid signal sequence from pre-proapoA-I 
(McGuire, Davidson et al. 1996). The propeptide sequence of 6 amino acids is 
removed by an unknown protease, releasing the mature apo A-I protein. 
Inspection of the amino acid sequence of pre-proapo A-I and apo A-I reveals that 
a large part of the protein evolved by duplication of a primordial sequence 
encoding a 22 amino acid sequence (22-mer). This primordial sequence seems to 
have evolved by a duplication of an 11-mer sequence (Boguski, Elshourbagy et 
al. 1985).  
Synthetic amphipathic helical segments whose primary sequence is 
unrelated to that of native apo A-I can be effective mimics of natural apo A-I in 
binding to phospholipids, promoting cholesterol efflux from cells, and activating 
the formation of cholesteryl esters by the LCAT reaction (Nion, Demoor et al. 
1998; Wool, Reardon et al. 2008). Some repeats in native human apo A-I have 
been reported to be of more significance than others for the function of HDL 
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particles (Sorci-Thomas, Curtiss et al. 1997). The reports indicate that apo A-I 
may retain significant tertiary structure 
3.3.3 Hi-yield Expression and Purification Strategy for Apo A-I 
Hi-yield heterologous expression of apo A-I was optimized by adapting 
strategies previously reported for human apo A-I expression and purification 
towards zebrafish apo A-I (McGuire, Davidson et al. 1996; Rogers, Roberts et al. 
1998; Bayburt, Grinkova et al. 2002). A hexa-histidine tag was introduced 
upstream of the N-terminus of zap1 in the bacterial expression plasmid. The zap1 
cDNA contained some rare codons for E.coli due to which an engineererd E. coli 
strain was chosen which contains an additional plasmid coding for rare E. coli 
amino acids (BL21DE3 Rosetta2) instead of codon optimizing the DNA. The 
bacterial strain chosen was also deficient in proteases, since apo A-I being a 
flexible protein, could be susceptible to proteolysis in the bacterial cell. Evidence 
of truncated proteins was observed however, and may be attributed to aborted 
protein translation in E.coli. Enriched bacterial culture media, called Terrific 
Broth, was used to maximize bacterial growth. The bacterial cells were lysed in 
the presence of a chaotrope (6M guanidine hydrochloride) or detergent (1% 
Triton X-100) in order to solubilize the hydrophobic stretches of apo A-I by 
delipidation for further purification. 
In a solution of 6M guanidine hydrochloride or 1% Triton X-100, the apo 
A-I is mostly unfolded. The apo A-I is refolded on the Ni column by washing the 
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column with decreasing concentration of guanidine hydrochloride or Triton X-
100. On-column labeling of zap1Q26C may be performed in a partially unfolded 
state of the protein by flowing the maleimide-functionalized fluorophore at 
approximately 1mM concentration in the wash buffer without any reducing agent. 
If Triton X-100 is used for solubilization, then a washing step with 2mM sodium 
cholate is recommended to separate any charged impurities. The final washes of 
the Ni column are chaotrope or detergent free. The protein is eluted using an 
imidazole gradient. Gel-filtration chromatography is carried out to obtain 
fractions with ful-length zap1 at different purities (Fig. 1-3 C). We have observed 
both zebrafish and human apo A-I to have a strong tendency to form non-covalent 
dimers and tetramers when free of chaotropes or detergents. Full-length apo A-I 
of very high purity (>92%) may be isolated from the gel-filtration peaks 
corresponding to a tetramer. The monomer peak usually overlaps with a peak 
containing truncated protein in a Superdex 200 column and is thus not usable. 
The pure apo A-I may be stored for extended periods of time at 4°C or in 
standard buffers without any loss in lipid-binding activity. The apo A-I does tend 
to aggregate over time, therefore it is advisable to store small aliquots at -20°C. 
When thawing an aliquot for use, it is advisable to centrifuge the tube and make a 
fresh dilution of apo A-I from the supernatant and determine the concentration (by 
UV absorbance) before starting an experiment. 
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3.3.4 Molecular Basis of in-vitro Discoidal Lipoprotein Formation by Apo 
A-I 
Salt bridges are weak, ionic forces between positively and negatively 
charged side chains of amino acids. The contribution of a single salt bridge may 
be as much as –5 kcal/mol (Schulz G.E. and R.H. 1979) and is heavily dependent 
on the electrostatic properties of the medium. The contributions of salt bridging 
are more important for determining specifity between protein-protein interactions, 
rather than the overall stability of the protein. If the charges of oppositely charged 
proteins, or protein surfaces are not compensated, the energy is reduced 
sufficiently such that the proteins will not associate. 
Most of the experimental evidence on apo A-I and HDL structure has been 
obtained from synthetic recombinants of human apo A-I and pure phospholipids 
in a range of relative molar ratios. The particles have been shown to consist of a 
planar phospholipids bilayer, whose edges are sealed from the aqueous medium 
by apo A-I. It was thought earlier that a ‘picket fence’ model- where the helical 
repeats of apo A-I were at right angles to the lipid bilayer, accurately reflected the 
structure of these particles (Brasseur, De Meutter et al. 1990; Phillips, Wriggers et 
al. 1997). The more recent ‘double belt’ model predicts the helical repeats to be 
aligned circumferentially parallel to the bilayer (Segrest, Jones et al. 1999; 
Tricerri, Agree et al. 2001). The double-belt model of apo A-I binding to lipids is 
the currently accepted model. 
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Figure 3-7. Intermediates in a Micelle-to-Vesicle Transition 
 
 
Schematic representation of a proposed micelle-to-vesicle 
transition pathway adapted from Leng et al. (Leng, Egelhaaf et al. 2003). 
Detergent removal from mixed micelles is believed to first form disc-like 
intermediate micelles rapidly. These micelles grow up to a certain critical 
radius (r*) due to coalescence, followed by closure to form vesicles. 
Ripening of these vesicles is thought to occur over very long timescales. 
Under certain conditions, there may be a significant barrier to coalescence 
(depending on electrostatic interactions between disks and packing 
contributions), and growth and closure may be slower than stacking. This 
leads to the formation of lamellar phase as the end state. 
In a NABB, apo A-I may replace the detergent at the edge of the 
disc, thereby increasing the stability of the kinetically trapped discoidal 
intermediate (section 3.3.4). 
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Discoidal lipid particles are hypothesized to be intermediates in a micelle-
to-vesicle transition reaction of lipids upon detergent removal, as deduced from 
static and dynamic light scattering experiments (Leng, Egelhaaf et al. 2003). In 
the absence of apo A-I, when a detergent is removed from a mixed-micellar state 
of lipids and detergents, disc-like intermediate micelles are first formed rapidly 
(Fig. 3-7). These disc-like micelles grow by coalescence. Interactions between 
disc-like micelles are determined by the standard electrostatic potential of the 
system in addition to local packing contributions between the discs. Large discs 
then become unstable due to incomplete coverage of their perimeter by detergent 
which increases the energy per unit length of boundary (line tension) of the disc, 
finally leading to closure of the large lipid disc to form a lipid vesicle. Line 
tension may control the initial diameter of the disc-like micelles. 
It is plausible that apo A-I present at a certain concentration replaces the 
surfactant stabilizing the edge of the bilayer due lipid-binding properties of its 
amino acids, as shown in red in Fig. 3-7. This would provide kinetic stability to 
the disc-like micelle formed. It should be mentioned that this proposed scheme of 
NABB formation is valid only when NABBs are formed by detergent removal 
from a mixed micellar state. Human apo A-I is able to directly solubilize vesicles 
around their phase transition temperature (Tm) of the vesicle lipids (Tricerri, 
Toledo et al. 2005). The vesicles formed with dimyristoyl phosphocholine 
(DMPC, Tm= 28°C) or dipalmitoyl phosphocholine (DPPC, Tm= 40°C) are 
among those that are solubilized by apo A-I. The NABB formation pathway in 
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these cases likely involves interaction of apo A-I with lipids facilitated by 
interfacial packing defects in the lipids during the gel to liquid-crystalline phase 
change. Using lipids such as 1-palmitoyl-2-oleoyl phosphocholine (POPC,  
Tm= –3°C) or 1-palmitoyl-2-oleoyl phosphoethanolamine (POPE, Tm= 17°C) 
(Leekumjorn and Sum 2007), which are already in liquid crystalline phase under 
experimental conditions, detergent removal is the preferred method for formation 
of NABBs.  
3.3.5 Electron Microscopy of Discoidal Lipoprotein Particles 
Electron microscopy (EM) is an extremely useful tool for obtaining insight 
into particle size distributions and morphology under conditions where sample 
size is extremely small and/or dilute. Biological materials examined by EM 
generally have poor inherent electron scattering characteristics. A commonly used 
solution is using negative-staining where heavy metal salts are used that can be 
air-dried to give an amorphous electron-dense layer surrounding and supporting 
(embedding) the biological particles (Harris 1997). Negative-stain EM lends itself 
extremely well in examination of smaller, dense lipoproteins such as low-density 
lipoproteins (LDL) and high-density lipoproteins (HDL) (Forte, Nichols et al. 
1971; Wlodawer, Segrest et al. 1979; Bayburt and Sligar 2003; Catte, Patterson et 
al. 2006). Negative-stains commonly used in EM are uranyl acetate, 
phosphotungstate, and ammonium molybdate. Uranyl acetate is favored for most 
applications because of its low-granularity and high contrast. The pH of this stain 
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is 3.5 to 4.0 and can only be used for dilute protein samples, otherwise 
aggregation and precipitation of the protein may occur. 
We performed negative-stain EM on 400-mesh formvar carbon coated 
grids. The grids were glow-discharged for 20-30 sec prior to sample application to 
render them hydrophilic to not have the lipoprotein particles orient in any 
particular order. The lipoprotein particles were freshly prepared and examined in 
the electron microscope within 1 hour of preparing the grid. To get good contrast, 
a relatively low accelerating voltage of 80 kV was used in the microscope. An 
optimal defocus was used for imaging, one that showed minimal granularity of 
the background stain. Each grid was adequately sampled by taking random 
images within a grid square and then imaging in random grid squares to get a 
representative set of particles for analysis. 
Aggregation of lipoprotein particles on the grid provide additional 
information on the physical properties of the particles. Under negative-staining 
techniques, discoidal lipoproteins form ‘stacks’ or rouleaux owing to their planar 
shape and discoidal geometry. These structures were predominantly seen at 
defined lipid:apo A-I ratios, indicating the optimal stoichiometry of components 
required to form small, discoidal particles having the thickness of a phospholipids 
bilayer.    
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4.0   
Site-Specific Labeling of Rhodopsin 
4.1 Introduction 
Derivatization of GPCRs with fluorescent probes at a specific site and 
their characterization is a crucial and challenging step in elucidating the molecular 
mechanisms of GPCR activation. Chemical modification of an amino-acid side 
chain with a fluorophore of small molecular weight is a desirable strategy for 
labeling to detect relative conformational change between protein microdomains 
or monitoring oligomerization of proteins. The sulfhydryl group of cysteine side 
chains is the first target for such modifications because of the following reasons: 
1. The cysteine content of most proteins is relatively low (< 3 mol%) 
allowing easy discrimination and identification of individual 
sulfhydryl groups. 
2. A large variety of very specific reagents are commercially available, 
including compounds that introduce reporter groups for 
spectrophotometric, fluorometric, ESR, NMR, and biochemical 
analysis. 
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3. The SH group reactivity is fast without the requirement of a catayst. 
 
Bovine rhodopsin has 10 cysteine residues at positions 110, 140, 167, 185, 
187, 222, 264, 316, 322 and 323 (Hargrave, McDowell et al. 1984). Cys 110 and 
187 form a disulfide bond, Cys 322 and 323 are palmitoylated and Cys 167, 222 
and 264 are buried inside the transmembrane helices (Palczewski, Kumasaka et 
al. 2000). Previous studies have indicated that Cys 140 and Cys 316 on the 
cytoplasmic side are found to be reactive towards maleimide and iodoacetamide, 
and of these residues, Cys 316 appears to be more reactive (Findlay, Barclay et al. 
1984; Imamoto, Kataoka et al. 2000). In this chapter we discuss methods used to 
label and characterize bovine rhodopsin at these reactive cysteine residues. 
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Figure 4-1. Fluorescent Derivatization of Rhodopsin 
 
 
(A) Stochiometry of rhodopsin labeling by commercially available 
maleimide-linked fluorophores. Plot of the molar excess of dye (x axis) 
and the final labeling ratio of detergent solubilized, affinity purified 
rhodopsin (y axis) determined by UV-visible difference photobleaching 
spectroscopy. For most dyes, the extent of labeling increases linearly with 
increasing dye concentration above a certain threshold. (B) Detection of 
site-specific labeling using V8 protease digestion of labeled rhodopsin. 
Coomassie stained gel lanes containing unlabeled rho (lane 1), V8 
digested Atto655:rho initial ratios of 9:1 (lane 3) and 3:1 (lane 4) are 
shown. Fluorescence detection of the gel was done prior to Coomassie 
staining. The fluorescence of the respective Atto655 labeled rho samples 
are shown in lane 5 and 6. V8 digestion of rho results in two main 
proteolyzed fragments- F1 and F2. Cys 316 is present in the F2 fragment. 
Selective modification of Cys 316 may be inferred from the fluorescence 
signal appearing exclusively in the F2 fragment in lane 6, compared with 














4.2.1 Rhodopsin Labeling with Fluorophore Maleimides 
The relation between molar excess of different dyes at the start of the rho 
labeling reaction and the final molar ratio of dye to rho is shown in Fig. 4-1. The 
fluorophores used exhibited differences in the optimal molar ratios required to 
achieve stoichiometric labeling of rho in ROS. When the dyes were used at 
equimolar ratios to rho, all of them resulted in sub-stoichiometric labeling of rho. 
Among the dyes tested, Alexa-546 led to the most efficient labeling of rho in 
terms of lowest dye excess required to achieve stoichiometric labeling (1:1 
Dye:Rho). Atto-655 also exhibited efficient labeling of rho and appeared to be an 
ideal fluorophore in the long-wavelength region to label rhodopsin. 
Stoichiometric labeling was achieved with a 3-times molar excess of Atto-655 
over rho, and two cysteines could be modified by doubling the initial dye excess 
(9-fold molar excess over rhodopsin) (Fig. 4-1 A).  
Rhodopsin was labeled in ROS in order to enhance the reactivity 
difference between the two accessible cysteines– Cys 316 (more reactive) and 
Cys 140 (less reactive). We assumed that Cys 316 and Cys 140 would get 
sequentially modified by the maleimide dyes due to their reactivity difference. To 
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test this assumption, we carried out V8 protease digestion of labeled rhodopsin 
and analyzed the fragments for fluorescence using SDS-PAGE (Fig. 4-1 B). V8 
protease cleaves rho mainly into 2 fragments with Cys 140 being part of the larger 
fragment F1 (~27 kD) and Cys 316 being a part of the smaller fragment F2 (~13 
kD) (Farrens, Altenbach et al. 1996). As seen from the gel, the stoichiometric 
labeling condition for rho using Atto-655 (3:1 Atto-655:rho) predominantly 
modifies Cys 316. 
4.2.2 Rhodopsin Labeling with Nanogold Maleimide 
 Nanogold® (Nanoprobes, NY) is a homogenous 1.4nm gold cluster that 
is designed for covalently labeling biomolecules under mild conditions and 
physiological buffers. The size of the gold cluster and number of gold atoms 
forming a cluster in the Nanogold reagent (~67 Au atoms) is between the smaller 
Undecagold (0.8nm, 11 Au atoms) and the larger collidal gold (10nm) reagents 
(Hainfeld and Powell 2000). This enables Nanogold to be visualized directly by 
transmission electron microscopy (TEM), while reducing the non-specific 
adsorption characteristics of larger, colloidal gold.  
We were able to efficiently link monomaleimido nanogold to rhodopsin 
using methods developed for fluorophore maleimides. The main differences were 
a twofold higher rho concentration was used in the nanogold labeling reaction 
compared with fluorophores (Method 2.4), and the mixture was not shaken during 
incubation. After purification of rho, the labeling stoichiometry was determined 
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by comparing the twin absorbances of nanogold at 280nm ( 280= 2.25 x 10
5  
M-1cm-1) and 420nm ( 420= 1.12 x 10
5 M-1cm-1) with the difference spectrum of 
rhodopsin. Using our labeling method, we obtained 0.8–0.9 nanogold per rho. We 
assumed that Cys 316 would have been modified at these labeling ratios, similar 
to fluorophore labeling experiments (Method 2.3). We reasoned that the larger 
size of the nanogold gold cluster, compared to a fluorophore molecule, may 
preclude its accessibility to the other Cys residues. The labeling ratio was further 
checked by negative stain electron microscopy using dilute NG-rho (nanogold 
labeled rho) samples and 1 NG-rho-NABB on the grid. 
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4.3 Discussion 
The sulfhydryl groups of bovine rhodopsin have been reported to exhibit 
clearly different reactivity/accessibility upon treatment with SH reagents (De Grip 
and Daemen 1982). The differences depend on the following conditions-  
1. Type of reagent used. 
2. The microenvironment of rhodopsin. 
3. Illumination condition of rhodopsin. 
In this case, we chose to label rhodopsin by using only maleimide 
functionalized fluorophores. The fluorophores have different chemical structures 
which would affect the hydrophobicity of the probes as well as its size. Both these 
factors could control the accessibility of the probes to the cysteine residues on the 
cytoplasmic side. The microenvironment of rho in all cases was chosen to be the 
native ROS membranes. It is possible that the phospholipid headgroups of the 
ROS also play a part in modulating accessibility of the probes to Cys 140 which is 
closer to the lipid headgroups than Cys 316. Only very small, hydrophobic 
reagents like methylmercury iodide, used at 90-fold molar excess over rho can 
modify all cysteines in rhodopsin under similar conditions (Daemen, Van Breugel 
et al. 1976). 
The stoichiometry profile of the maleimide probes to the cysteines in rho 
presented in this chapter is strictly dependent on the presence of a lipid bilayer. 
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When rhodopsin is solubilized in detergents, more cysteines were available for 
reaction with the probes (De Grip and Daemen 1982). The relative reactivity 
difference between Cys 140 and Cys 316 may be diminished due to the more 
disordered character of detergent micelles or detergent-induced changes in protein 
conformation. Interestingly, it has been reported that the reactivity difference 
between cysteines is maintained in digitonin, which forms rigid micelles where 
detergent-lipid exchanges are minimal (Hong and Hubbell 1973). 
Since the labeling reactions are carried out on ROS, care should be taken 
to protect the cysteines from air oxidation, particularly since the ROS contains a 
large proportion of unsaturated membrane lipids. The ROS was therefore flushed 
with Argon to keep the sulfhydryl groups in a reduced state and remove traces of 
reactive oxygen species, and EDTA containing buffers were used to chelate traces 
of heavy metals. Maleimides start to react slowly with amino groups above pH 7, 
therefore the pH was kept between 6 – 7 using a buffer that is not temperature 
dependent (in this case, HEPES or sodium phosphate). Temperature and time of 
the reaction are very highly correlated in these reactions. Below 20°C, reaction 
rates with hydrophilic reagents decrease considerably and above 30°C, thermal 
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5.0   
Studies on Rhodopsin Monomers and Dimers 
Incorporated into NABBs 
5.1 Introduction 
G protein-coupled receptors (GPCRs) are excellent examples of allosteric 
proteins (Huber and Sakmar 2008). Knowledge about the functions of GPCRs and 
biological processes governing their regulation has been increasing at an 
accelerated rate. One of the aspects that can be reconciled with the allosteric 
nature of many GPCRs is their ability to form homo- and heterodimers and higher 
oligomers. For example, hetero-dimerization between two isoforms of the 
GABAB receptor has been shown to affect cell-surface localization (Margeta-
Mitrovic, Jan et al. 2000). Co-immunoprecipitation techniques have been used in 
reports of receptor homodimerization in the case of metabotropic glutamate 
receptor (Romano, Yang et al. 1996) and 2-adrenergic receptor (Hebert, Moffett 
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et al. 1996) whereas cross-linking and bioluminescence resonance energy transfer 
(BRET) have been used in reports of oligomerization of dopamine D2 (Guo, 
Urizar et al. 2008). Most of the convincing reports of GPCR dimerization have 
dealt with family C GPCRs (section 1.1). Even in these cases, the functional 
consequences of a GPCR dimer towards G protein coupling, in a system free of 
accessory proteins, is not known.  
For rhodopsin, a prototypical family A GPCR, a wide variety of assays 
have been applied by a number of research groups to determine whether 
rhodopsin exists as a monomer or a homo-dimer/ higher oligomers, similar to 
other known GPCRs in the native state (Fotiadis, Liang et al. 2003; Jastrzebska, 
Maeda et al. 2004; Chabre and le Maire 2005; Kota, Reeves et al. 2006). 
Attempts towards answering the question of whether rho dimerization is required 
for transducin signaling has not led to a consensus, primarily because it has not 
been possible to isolate rhodopsin monomers and dimers in a native-like well-
defined environment that is free from interference of accessory proteins, yet 
tenable for biochemical assays. In this chapter, we describe the first 
demonstration of a novel single-particle electron microscopy imaging technique, 
coupled with ensemble biochemical assays, to probe G protein activation rates by 
rhodopsin monomers and dimers isolated in a nanoscale native-like membrane-
mimetic systems, called NABBs (Chapter 3). We considered not only the 
oligomeric state, but also the relative orientation of two rhodopsins when they are 
incorporated in a NABB. We demonstrate that monomeric rhodopsin is sufficient 
for efficient activation of transducin, and infer the limits of G protein activity that 
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a putative physiological rhodopsin dimer may have. Defining the interaction of a 
G protein with the monomer or the oligomerization interface of a GPCR, in terms 
of catalytic center activity of the GPCR, could offer new pharmacological targets 




Figure 5-1. Gel-filtration Chromatography of Rho-NABBs 
 
Gel-filtration chromatography of rhodopsin-NABBs made by 
Extracti-Gel D mediated detergent removal (Materials and Methods) using 
Alexa-488 labeled zap1Q26C, LRB-DOPE doped POPC and Atto-655 
labeled rhodopsin on a Superose 6 10/30 column using an Akta Explorer 
10 FPLC system. The incorporation ratio was approximately 
0.1rho/NABB. Absorption at three wavelengths was recorded 
simultaneously: 280nm (protein absorbance), 570nm (LRB-DOPE 
absorbance) and 650nm (Atto 655 rho absorbance) indicating elution of 
total protein, lipid and rhodopsin from the column, respectively. (Top) 
Eluted fractions were analyzed by loading equal volumes on a NuPAGE 
4-20% Bis-Tris gel run with SDS-MES running buffer. SDS-PAGE was 
followed by fluorescence detection using a Typhoon 9400 gel scanner. 
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Table 2. Stoichiometry of Components for NABB Formation 






















2 rho / NABB 80.0 80 3.3 51.0 34.8 
1 rho / NABB 40.0 80 4.6 51.0 34.8 
0.1 rho / NABB 4.0 80 5.8 51.0 34.8 
0.01 rho / NABB 0.4 80 6.0 51.0 34.8 
0 rho / NABB 0.0 80 6.0 51.0 34.8 
 
(a) Rhodopsin was purified from bovine ROS using ConA-Sepharose affinity 
purification and stored as 400mM stock in 1.5% OG. (b) Zap1 (hexa-histidine 
tagged zebrafish apo A-I construct) was purified from E. coli using Ni-affinity 
and gel-filtration chromatography and stored as 0.6mM stock. (c) POPC was 
doped 1:100 with LRB-DOPE and stored as 13.1 mM stock in 1% sodium 
cholate. (d, e) OG and sodium cholate were stored as 10% (w/w) stocks in water. 
All components were stored at -80oC and thawed on ice before mixing. The 
components were vortexed and incubated at room temperature for 30 min prior to 
detergent removal either dialysis or Extracti Gel D in buffer T (Materials and 
Methods). 
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Figure 5-2. Affinity Purification and Spectroscopic Characterization 
of Rho-NABBs 
 
(A) Ni-NTA purification of a 1rho/NABB sample made with Atto-
655 labeled rhodopsin and Alexa-488 labeled zap1Q26C. The sample was 
eluted with 10mM EDTA. (B) UV-visible spectra of Ni affinity purified 
rhodopsin-NABBs made with different starting stoichiometries of 
rhodopsin : zap1 with POPC stoichiometry adjusted accordingly (see 
Table 2). Zap1 is His tagged and the NABBs are purified by the Ni 



















5.2.1 Characterization of Rhodopsin Incorporation into NABBs 
Dialysis (Method A) quantitatively removes detergents but can only be 
used efficiently for detergents with relatively high CMC values. We used a 
detergent removing gel, Extracti-Gel D (Pierce Biotechnology, Rockford, IL) to 
remove detergents with comparatively low CMC values and to accelerate the rate 
of NABB formation. The rate of detergent removal is expected to affect the 
pathway of discoidal self-assembly and the particle size distribution (Rigaud, 
Pitard et al. 1995). NABBs formed using Extracti-Gel D formed sharper gel-
filtration profiles compared to detergent dialysis. Fig. 5-1 shows gel-filtration of 
rho-NABB complexes made with Alexa-488 conjugated zap1Q26C, lissamine 
rhodamine B sulfonyl DOPE (LRB-DOPE)– doped POPC and Atto-655 labeled 
rhodopsin where the starting reconstitution stoichiometry was 1 rho per 10 
NABBs. We used different starting molar ratios of rhodopsin to zap1 and POPC 
(NABB components) to form NABBs and subjected them to small-scale batch 
purifications using Ni affinity (Fig. 5-2 A). The unbound fraction contains 
rhodopsin in vesicles and/or aggregates. Fig. 5-2 B shows the UV-visible spectra 
of rho-NABBs made with different rhodopsin concentrations at a constant zap1 
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concentration after Ni affinity purification. The final A500:A280 ratios are in good 
agreement with the initial stoichiometries of the reactions, indicating that 
rhodopsin incorporation in NABBs is efficient and controllable. 
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Figure 5-3. FRET between Multiple Rhodopsins in a NABB 
 
(A) FRET emission profiles of Alexa-647 labeled rhodopsin in 
samples containing an equal mixture of Alexa-546 rho (Rd) and Alexa-
647 rho (Ra), with decreasing rho/NABB ratios. In each NABB formation 
reaction, the rho concentration was constant and the relative proportion of 
POPC and apo A-I were increased. 10nM rho in NABBs was used in the 
cuvette for FRET measurements. The data are normalized to donor 
(Alexa-546) emission. (B) Ratio of Alexa-647 emission to Alexa-546 
emission calculated from (A). The red bar corresponds to a 2 rho/NABB 
ratio and the blue bar to a 1 rho/NABB ratio. (C) FRET emission profiles 
of Alexa-647 labeled rho in samples containing similar amounts of lipids 
(POPC) as in (A) but with no apo A-I. (D) Ratio of Alexa-647 emission to 
Alexa-546 emission calculated from (C). The color of the bars correspond 
to the emission profile of the sample in (C). 
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5.2.2 FRET between Multiple Rhodopsins in a NABB 
To determine whether rhodopsin forms constitutive dimers in a detergent 
solubilized form, we used increasing stoichiometry of NABB components (lipids 
+ apo A-I) at a specific rho concentration in an attempt to form reactions where a 
2 rho/NABB would be able to get ‘diluted’ out into 1 rho/NABB. We wanted to 
test whether the 2 rhodopsins stay in a single NABB when given the possibility of 
partitioning into separate NABBs. If rhodopsin had a strong, constitutive tendency 
to dimerize, it would not dissociate from the other rhodopsin in detergent, or 
when the detergent is removed to form NABBs. To test for rho dimerization, we 
carried out Fluorescence Resonance Energy Transfer (FRET) experiments 
between rho labeled with a donor fluorophore (Alexa-546) and rho labeled with 
an acceptor fluorophore (Alexa-647) mixed in equimolar ratio in the NABB 
formation reaction. Details about labeling and characterization of labeled 
rhodopsin are given in the preceding chapter. The Förster radius of the Alexa-546 
– Alexa-647 pair has been reported to be 6.8nm (Molina, Barrera et al. 2006). If 
two rhodopsins with different labels were farther than 6.8nm apart from one 
another, a decrease in the emission signal of the acceptor fluorophore (therefore 
the FRET index) would be seen. The average diameter of a NABB is 10nm and 
since the rhodopsins were reconstituted into NABBs from a detergent-purified 
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state, a decrease in FRET index would also imply that the rhodopsins have been 
incorporated into distinct NABBs. 
We observed a decrease in FRET between rhodopsins in reactions that 
contained increasing amounts of lipids and apo A-I compared to rho, as shown in 
Fig. 5-3. A sharp decrease in FRET was seen when the NABB stoichiometry is 
increased to accommodate 1 rho per NABB. Increasing the amount of unlabeled 
rhodopsin in the reaction, while keeping the relative ratio of lipids and apo A-I 
constant (corresponding to 2 rho/NABB) also showed a similar drop in FRET 
index.  
The FRET data indicate that 2 rhodopsins do not constitutively dimerize 
when solubilized and purified in 1.5% octylglucoside containing buffer. When the 
ratio of lipids and apo A-I is increased such that the rhodopsins may either stay in 
the same NABB (maintain FRET) or distribute in separate NABBs (lose FRET), 
the rhodopsins tend to distribute into separate NABBs. A vesicle control was 
performed under similar rho and POPC concentrations but with no apo A-I added. 
The drop in FRET in vesicles is seen due to rhodopsin dispersion due to 
increasing lipid:rho ratio. Notably, the FRET values in vesicles are much higher 
than in NABBs, even though the same rho concentration was used in the cuvette 
in both experiments. The higher values are likely to be because of rhodopsin 
aggregates in vesicles where one donor may transfer energy to more than one 
acceptor in its vicinity. Since the Förster radius of the fluorophore pair (6.8nm) is 
larger than the thickness of a typical phospholipids bilayer (5nm), we expect 
efficient energy transfer to occur even if the 2 rhodopsins are incorporated anti-
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parallel to one another, both in NABBs and in vesicles. Using the Alexa-546 – 
Alexa-647 fluorophore pair and ensemble FRET measurements, we were able to 
determine proximity of the rhodopsins within 6.8nm but not the ‘sidedness’ of 
incorporation of the rhodopsins. 
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Figure 5-4. Electron Microscopy of Rho-NABBs 
 
(A) (Top) Nanogold-labeled rhodopsin in 2 rho-NABB samples 
imaged under negative stain in 0.5% uranyl acetate (UA). (Bottom) 
Histogram of number of nanogolds per NABB in 816 NABB particles 
chosen for analysis. 2 nanogold labels were visible in about 70% of the 
particles. (B) Single particles of 2 or 1 nanogold labeled rhodopsin-
NABBs (NG-rho-NABBs) selected from nanogold labeled 2rho-NABB 
and 1rho-NABB EM images. Nanogold densities in the NABB are 
indicated with arrows. Outer edge of each box is 20nm in scale. (C) (Top) 
Gel-filtration of 2Fab-rho-NABB complexes on a Superose 6 10/30 
column. The peak of 2rho-NABB is shown for comparison. (Bottom) 
Electron micrograph of 2Fab-rho-NABB shown under negative stain 
conditions using 1% UA. (D) Representative set of single particles 
obtained by epitope mapping of rhodopsin in NABBs using Fab. (Top) 
Single particles of 2Fab-rho-NABB grouped into anti-parallel and parallel 
orientation of rhodopsins in a NABB. A central ‘hole’ is clearly visible in 
the Fab fragments consistent with electron micrographs of Fab particles 
(Boisset, Radermacher et al. 1993). Orientation of Fab particles with 
respect to the central NABB density is depicted in a cartoon representation 
below each particle. Outer edge of each box is 30nm in length. (Bottom) 
Relative proportion of anti-parallel and parallel rhodopsins in 2Fab-rho-
NABB samples determined by visual classification of Fab density with 
respect to NABB density from single particles of 2Fab-rho-NABB. 
Cartoon representations of the orientations of the particles on the grid 
considered for the analysis are shown on the y-axis. Representation a 
depicts anti-parallel rhodopsins in NABBs that are observed with the label 
on rhodopsin in a staggered or perpendicular position to the NABB 
density. Representation b depicts 2 rhodopsins in a parallel orientation.  
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5.2.3 Determination of Orientation of Multiple Rhodopsins in a NABB 
In order to visualize the incorporated rhodopsins in NABBs, rhodopsin-
specific labels with no cross-reactivity with the lipid or apolipoprotein in the 
NABB were used. Rhodopsin was labeled site-specifically with nanogold and 
imaged by negative stain EM at very dilute rho-NABB concentrations (Fig. 5-4 A 
upper panel). The defocus used to image nanogold was typically less than the 
defocus used to visualize proteins (Hainfeld, Powell et al. 2002). At optimum 
underfocus values, the nanogold densities are clearly visible as high-density 
structures together with NABBs that appear as low-density structures over the 
background. Single particles were selected from individual micrographs using a 
semi-automatic selection (‘boxing’) procedure using the ‘Boxer’ software, part of 
the EMAN 1.7 suite of applications (Lüdtke, Baldwin et al. 1999). The nanogold 
labeled rho-NABBs were tenable to statistical analysis by counting the number of 
nanogolds per NABB. As shown in Fig. 5-4 A lower panel, more than 80% of the 
selected particles had at least two rhodopsins and approximately 70% of particles 
contained exactly two rhodopsins. 2 rho-NABBs and 1rho-NABBs can be clearly 
identified by the nanogold density (shown by arrows, Fig. 5-4 B) in the 
representative images. Thus, EM images may be used as further proof of 
stoichiometry of rhodopsin incorporation into NABBs. 
In order to determine orientation of multiply incorporated rhodopsins, we 
chose to image rho-NABBs as a macromolecular assembly with anti-rhodopsin 
Fab fragments bound to the C-terminus of rhodopsin in NABBs. We confirmed 
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the formation of a stable 2Fab-rho-NABB complex by FPLC (Fig. 5-4 C upper 
panel). The EM image of the macromolecular complex with 1% UA staining is 
shown in Fig. 5-4 C lower panel. We propose that the NABBs are an effective 
tool to image complexes of transmembrane receptors with associated signaling 
molecules. 
We analyzed Fab labeled rho-NABBs to ascertain the relative orientation 
of two rhodopsins in a single NABB. In the case of Fab labeled particles, only 
those particles were analyzed which have the NABB density approximately 
perpendicular to the plane of the grid in order to be able to be able to discern the 
Fab density which would be perpendicular to the characteristic NABB ‘discoidal’ 
density. The set of selected particles were subjected to visual inspection and 
classified into either anti-parallel or parallel from the relative orientation of 
nanogold or Fab density with respect to the central lipoprotein density. We 
analyzed single particles picked from high defocus (  3μm) images of 2Fab-rho-
NABB particles to classify the orientation of the C-termini of the two 
incorporated rhodopsins with respect to each other. For clarity, we chose only 
those particles where the zap1 belt was oriented perpendicular to the plane of the 
grid as these particles were the ones where the Fab positions could be detected 
unambiguously with respect to the belt (Fig. 5-4 C lower panel). Analysis of 
single particle images from Fab labeled 2rho-NABBs show that approximately 
half of all the NABBs containing two rhodopsins contained the rhodopsins in an 
antiparallel orientation with respect to each other (Fig. 5-4 D). 
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Figure 5-5. Thermal Stability of Rho-NABBs 
 
Rho-NABB samples were made by detergent removal using 
Extracti-Gel D (Method 2.15). The samples were Ni affinity purified 
before analysis. Thermal stability of rhodopsin in various environments as 
indicated determined by UV-vis difference photobleaching spectroscopy. 
Each data point represents the average of three independent experiments. 















5.2.4 Thermal Stability of Rho in NABBs 
We compared thermal denaturation of rhodopsin in NABBs with 
rhodopsin in ROS and detergents commonly used for rhodopsin biochemistry. 
Thermal denaturation of rhodopsin occurs at a higher threshold temperature when 
it is in rod disc membranes compared with detergent (Hubbard 1958; Knudsen 
and Hubbell 1978). We observed that the denaturation temperature of rhodopsin 
in NABBs is similar to rhodopsin in ROS (Fig. 5-5). The data indicate that 
increasing the hydrophobic chain lengths of detergents (OG to DM), and 
substituting the non-ionic head group (OG or DM) by the zwitterionic head group 
of phospholipids (in NABBs or ROS membranes) both lead to substantial increase 
in thermal stability. There seems to be a slight decrease in the denaturation 
temperature when two rhodopsins inhabit a NABB compared to a single 
rhodopsin per NABB and this decrease may reflect the difference in the number 
of POPC molecules surrounding the rhodopsins and/or packing defects of the 
lipids in the reduced space between rho and apo A-I. The stoichiometry at the 
start of the self-assembly of the two rho per NABB particle has only 42 lipids 
surrounding each rhodopsin (21 per leaf of the bilayer). While this number of 
lipids may be comparable to the number of lipids surrounding rhodopsin in ROS 
(Miljanich and Dratz 1982), it is only 35% of the 116 lipids surrounding 
rhodopsin in a one rho/NABB case. The remarkable thermal stability of 
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rhodopsin(s) in a NABB indicate that a minimal amount of lipids surrounding 
rhodopsin is sufficient to preserve its conformational state and thermal stability 
may not depend upon long range lipid interactions. 
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Figure 5-6. Meta-II Decay and Opsin Regeneration 
 
(A) Meta-II decay kinetics of one or two rhodopsins in NABBs 
probed by Trp fluorescence increase as a function of time after bleaching. 
Excitation wavelength 295nm, emission wavelength 330nm, integration 
time 2 s. Data were fit to a pseudo first-order kinetics to determine the 
half-life times of Meta-II decay. Values are averages of three independent 
experiments. (B) Regeneration of opsin in NABBs (1 opsin per NABB) 
probed by absorbance spectroscopy at 520nm. Absorbance was recorded 
in 3 s intervals with an integration time of 1 s. Opsin formed by 
photobleaching a 1rho-NABB sample (Method 2.21) was regenerated by 
stoichiometric amount of 11-cis-retinal dissolved in empty NABBs (red 
curve). Addition of 11-cis-retinal to empty NABBs is also shown (black 
curve). The regenerated rhodopsin in NABBs was stable to treatment with 














5.2.5 Meta-II Decay and Regeneration of Opsin in NABBs 
Meta-II decay of rhodopsin was followed by monitoring the change in Trp 
fluorescence to determine the Meta-II decay kinetics of rhodopsin(s) incorporated 
in a NABB. We found that the Meta-II intermediate in one rho-NABBs has a half-
life of 17 min and Meta-II in two rho-NABBs has a slightly longer half-life of 20 
min (Fig. 5-6 A). These values correlate with our data showing differences in the 
fraction of deprotonated Schiff base formed upon actinic light exposure and are in 
good agreement with previous reports of rhodopsin Meta-II decay assays (Heck, 
Schädel et al. 2003; Jastrzebska, Maeda et al. 2004). 
Opsin-NABB formed after Meta-II decay of rhodopsin was able to 
regenerate rapidly and quantitatively in the presence of stoichiometric amounts of 
11-cis-retinal (Fig. 5-6 B). Absorbance at 520nm was not affected by the 
absorption peak of free retinal (378nm) or nonspecific Schiff base formation. The 
rapid regeneration of opsin in NABBs compared with opsin in DM is probably a 
result of the dramatic difference in the partial volume fraction of the lipidic 
environment. A recovery of the characteristic difference spectra and lack of 
hydroxylamine sensitivity under conditions minimizing photobleaching implies 
that the added 11-cis-retinal forms a specific, protonated Schiff base linkage at 
Lys-296 of opsin to form regenerated rhodopsin. Photobleaching the sample in the 
presence of hydroxylamine greatly accelerates the decay of Meta-II. In the 
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presence of the deprotonated Schiff base form of retinal, hydroxylamine leads to 
the formation of a stable retinal oxime, a phenomenon that efficiently sequesters 
the chromophore out of the opsin. 
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Figure 5-7. Transducin Activation by One and Two Rho-NABBs 
 
The rho-NABB samples were 1D4 affinity purified to remove 
‘empty’ NABBs from interfering in the assay. Transducin activation by 
one and two rhodopsins per NABB probed by Trp fluorescence. 10nM 
rhodopsin(s) in NABB were photobleached in the presence of 100nM 
holotransducin and non-hydrolysable GTP analog (GTP- S). Fluorescence 
change of transducin due to 1rho-NABB (red curve) and 2rho-NABB 
(blue curve) and empty NABB (black trace) is shown. The rates are 
averages of three independent experiments. 
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5.2.6 G protein Activation by Rhodopsin Monomers and Dimers 
We measured the rates of transducin activation by rho-NABBs containing 
predominantly either one or two rhodopsins per particle (Fig. 5-7). The data were 
fit to an exponential of the form: 
y=a1 a2 e
kx 
with rate constant k. 1rho-NABB gave an apparent pseudo first-order rate 
constant ( kobs
(1) ) of 6 10 3 s 1 and the 2rho-NABB sample gave a value ( kobs
(1) ) of 
3 10 3 s 1. Since both samples contain the same rhodopsin concentration, the 
number of catalytic centers for transducin activation is the same in the monomers 
and dimers. If the dimers are a mixture of N different equally probable species 
and only one of them is active, then the activity of this species is N-times the 
activity of the monomer. The maximum activity of the parallel (physiologically 
relevant) rho dimer may thus be calculated by assuming that only the parallel 
dimer is responsible for the observed transducin activity. As suggested by EM 
imaging, N equals two, and considering only the parallel dimer to be active, the 
catalytic center activity (Segel 1993) of the dimer is same as that of the monomer. 
Consequently, the dimer is equally efficient in activating transducin compared 
with the monomer.  
The statements above may be rationalized further by comparison of 
transducin activation by rhodopsin in monomer and dimer form assuming it to be 
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an enzyme-catalyzed reaction between rho (enzyme) and transducin (substrate). 
Catalytic efficiencies of two enzymes may be compared by the ratio kcat Km  for 
the two enzymatic reactions. This ratio is also called the specificity constant and it 
is an apparent second-order rate constant with the units M 1s 1 (Nelson and Cox 
2004). The Turnover Number ( kcat ) may be specified as Molecular Activity or 
Catalytic Center Activity, depending on the definition of enzyme concentration 
(Segel 1993). Molecular Activity is defined as the number of moles of substrate 
transformed per minute per mole of enzyme. Catalytic Center Activity is defined 
as the number of moles of substrate transformed per minute per mole of active 
subunit or catalytic center. In the following derivations, we adopt the Catalytic 
Center Activity convention, since it has been hypothesized that a rho dimer 
interacts with a single transducin (Filipek 2005). The observed pseudo first-order 
rates of transducin activation are the products of  kcat Km  and the rhodopsin 
concentration. 
 
The observed rate of transducin activation by the rhodopsin monomer and 
dimer may be considered proportional to the concentration of rhodopsin in the 
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(1)  is the observed pseudo-first order rate constant of rho-NABBs for transducin 
activation, 
ki
(2) is the second-order rate constant of ith species of rho-NABBs for transducin 
activation, 
ci is the concentration of rhodopsin in the i
th species of rho-NABB, 
c0  is the total concentration of rhodopsin in rho-NABB, 
pi  is the probability of occurrence of the i
th species in a rho-NABB sample, and 
N is the total number of species possible in each rho-NABB sample. 
 
Consider two different cases of distribution of rhodopsin in rho-NABBs: 
 
Case 1: N species are equally probable and all N species are equally active 
(homogeneous case). 
 pi =1 N  
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From our experimental observations: 
The same rhodopsin concentration is present in the dimer (dim) and monomer 
(mon) samples: 
cdim = cmon  







(1)    
For rho dimer in 2rho-NABB, two species exist, thus  
N = 2 
 























(2)     (5) 
   
Thus in this case, the dimer is half as active as the monomer. 
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Case 2: N species are equally probable and only one out of the N species is active. 
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(2)     (7) 
 
Thus in this case, the active dimer has the same activity as the monomer. 
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The rationale for using N may be generalized further. It has been reported 
that a rhodopsin molecule may have three oligomerization interfaces and only one 
of them form the ‘true’ rhodopsin dimer physiologically (Liang, Fotiadis et al. 
2003; Suda, Filipek et al. 2004). Each oligomerization interface will lead to a 
distinct dimer where one rhodopsin may be considered to be rotated in-plane with 
respect to the other (see Fig. 1-4). These dimers may or may not be active towards 
transducin. To arrive at the maximum activity of the ‘true’ dimer, we assume that 
only the ‘true’ parallel dimer is active in a population of anti-parallel and parallel 
(N=2) and three sub-populations of parallel dimers (N=6). The ‘true’ dimer will 
then have 3-times the catalytic center activity of the monomer. If any of the 
subpopulations are active towards transducin, then the ‘true’ dimer will have a 
correspondingly lower activity, until all the subpopulations have equal activity 
and the activity of the dimer becomes equal to the monomer.  
In conclusion, we propose that the rhodopsin dimer in a lipid environment 
does not have dramatically higher activity compared with rhodopsin monomer as 
reported in detergents (Jastrzebska, Fotiadis et al. 2006). Earlier experiments 
performed in detergents which reported long-range rhodopsin oligomerization and 
markedly higher activity toward transducin by these oligomers (Jastrzebska, 
Fotiadis et al. 2006) are difficult to interpret since the detergent concentration 
effects may explain some, if not all, observations (Ernst, Gramse et al. 2007). Our 
experiments in NABBs do not suffer from this detergent concentration artifact 
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and hence we can propose the upper and lower limits of the G protein activity of 
the putative (physiologically relevant) rhodopsin dimer.  
148 
5.3 Discussion 
5.3.1 Characterization of Rhodopsin-NABBs 
We have demonstrated a method of rapidly incorporating the prototypical 
7-TM GPCR rhodopsin from a detergent purified state into a soluble, controllable, 
nanoscale lipid bilayer at high efficiency using apolipoprotein A-I, which we 
cloned from zebrafish. We have discussed a strategy for high-yield heterologous 
expression, purification and site-specific labeling of zebrafish apo A-I (zap1, 
zap1Q26C). Zap1 has favorable thermodynamics of interaction with POPC and 
proceeds to interact with POPC via an increase in its -helical character (Chapter 
3). A discoidal Nanoscale Apolipoprotein Bound Bilayer (NABB) is formed by a 
self-assembly process between lipids and zap1 triggered by detergent removal. 
Integral or peripheral membrane proteins present in the detergent mixture at a 
certain concentration become incorporated into the NABB.  
The enhancement of thermal stability of rhodopsin upon incorporation into 
NABBs is particularly striking. Many GPCRs show time-dependent loss of 
activity in detergents (Navratilova, Sodroski et al. 2005). Using our method of 
rapid incorporation into the phospholipid matrix of NABBs, long-term exposure 
to detergents may be avoided, thereby extending the resilience of the reconstituted 
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GPCR for in vitro studies. Thermal stability of rhodopsin is likely to be enhanced 
by shielding of the transmembrane hydrophobic area from water and satisfying 
specific chemical interactions with phospholipids on the protein surface. Local 
coupling of phospholipids to rhodopsin (Huber, Botelho et al. 2004; Soubias, 
Teague et al. 2006) results in long-range curvature elastic deformations in a 
bilayer membrane (Brown 1994), which influences the conformational energetics 
of the Meta-I/Meta-II transition and rhodopsin oligomerization (Botelho, Huber et 
al. 2006; Periole, Huber et al. 2007). Furthermore, we have demonstrated that the 
NABBs may be utilized for isolating either one or two receptors in absence of 
excess empty NABBs—a phenomenon that is not possible to achieve in detergent 
micelles.  
5.3.2 Single-Particle Analysis of EM Images 
The negative staining technique in electron microscopy has the advantage 
that the particles appear with high contrast, which enables a clear visualization of 
Fab fragments on the edge of discoidal NABB structures. However, this technique 
suffers from some shortcomings.  A certain amount of flattening of the particles is 
usually observed in negatively stained, air-dried samples. The extent of flattening 
is lower in regions of higher concentration of the negative stain (Boisset, 
Radermacher et al. 1993). Air drying and stain properties may cause aggregates of 
the molecules on the grid and exaggeration of the particle sizes, which limits the 
number of well-separated particles that can be obtained from a micrograph for 
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analysis. While a visual classification was possible, the lipoprotein particles had 
sufficient heterogeneity in shape to be intractable to more rigorous statistical 
analyses.  In the technique of cryo-EM, the molecules are entrapped in their 
native orientation in a layer of vitreous ice. The densities measured in cryo-EM 
reflect the projections of the biological material without any staining agent around 
the particle. However, while using charged lipoproteins like NABBs made with 
POPC as the lipid, the strong electron density of the lipid headgroups overwhelms 
the densities of proteins that are not sufficiently separated from the lipid bilayer. 
Cryo-negative staining may be an emerging technical improvement for imaging 
lipoprotein particles. Embedding the sample in vitreous ice after negative staining 
could reverse the strong electron density of the lipid headgroups under cryo-EM 
conditions, and allow acquisition of medium to high-resolution structural data of 
membrane proteins incorporated in these discoidal lipoprotein particles. 
An important unanswered question from previous work on putative rho 
dimers was the relative orientation of the two rhodopsins incorporated in a 
discoidal lipoprotein. Ensemble fluorescence based proximity methods (like 
FRET) could not be used since the properties of most commercially available 
fluorophores do not allow a clear resolution between parallel and anti-parallel 
dimers in a mixed population. We chose to undertake EM imaging followed by 
single-particle selection from the micrographs. We experimented with two 
complementary labeling techniques of rhodopsin which would enable us to 
measure the stoichiometry of rho incorporation and the position of the C-termini 
of rho when 2 rho were incorporated into a NABB. We chose previously 
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characterized NABB densities in EM images to select particles for our analyses. 
Our EM observations indicate that in approximately one-half of the NABBs with 
two rhodopsins, the rhodopsins are oriented anti-parallel to each other. This ratio 
was independent of whether the samples were prepared by dialysis or over 
Extracti Gel D columns, indicating that the process of ‘rhodopsin scrambling’ 
does not depend on the rate of detergent removal. The anti-parallel orientation in 
the 2Fab-rho-NABB (Fig. 5-4) had a profound impact when we attempted to 
determine the structure of the complex using the ‘common lines’ algorithm of 
single-particle averaging (Lüdtke, Baldwin et al. 1999), as seen in Appendix Fig 
A. The barrel shape of the complex is due to the influence of Fab density above 
and below the plane of the NABB. Averaging the Fourier Transform of the image 
class averages by imposing a C6 symmetry axis perpendicular to the plane of the 
NABB gives rise to a heavy ‘smear’ of density on both sides of the NABB. 
 
5.3.3 Insights into G protein Activity of a Putative Rhodopsin Dimer 
Compared to a Monomer 
Dimerization of family A GPCRs, particularly rhodopsin, is still a matter 
of intense debate (Chabre, Cone et al. 2003; Fotiadis, Liang et al. 2003; 
Jastrzebska, Maeda et al. 2004; Ernst, Gramse et al. 2007). A key question in the 
field is whether the rhodopsin monomer or putative dimer is the signaling unit for 
G protein activation. Model systems used to address this question are receptors in 
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detergent micelles, proteoliposomes, and recently, apo A-I stabilized phospholipid 
bilayer particles. Using detergent micelles, it has been claimed that dimeric 
rhodopsins have higher Gt activation rates than monomers (Jastrzebska, Maeda et 
al. 2004; Jastrzebska, Fotiadis et al. 2006). However, others have pointed out that 
the method is inappropriate to support the conclusions (Chabre and le Maire 2005; 
Ernst, Gramse et al. 2007). Work with rhodopsin in proteoliposomes has shown 
that dispersed rhodopsin is more active (Botelho, Huber et al. 2006). In line with 
this observation, Whorton et al. showed, using 2-adrenergic receptor ( 2-AR) 
reconstituted into HDL particles, that monomeric receptor is sufficient to activate 
G protein (Whorton, Bokoch et al. 2007). However, their work cannot exclude the 
possibility that receptor dimers may have substantially higher activity than 
monomers. Using a similar approach, Bayburt et al. have used one and two 
rhodopsins in Nanodiscs, and have concluded that dimerization is not necessary 
for efficient coupling of rhodopsin to transducin (Bayburt, Leitz et al. 2007). 
However, this conclusion is based on the assumption that two rhodopsins per 
Nanodisc form a physiologically relevant, parallel dimer. Here we show, using 
NABBs, that such structures formed with two rhodopsins contain a mixture of 
parallel and anti-parallel dimers.  
Together with the Gt activation results, and assuming that the parallel 
dimer is inactive, it follows that the active dimer has the same catalytic center 
activity as the monomer. As proposed in the rhodopsin “rows of dimers” model 
(Liang, Fotiadis et al. 2003), a rhodopsin molecule may have three 
oligomerization interfaces. If the parallel dimer consists of subpopulations of 
153 
dimers using these dimerization interfaces then only a fraction (1/3) will contain 
the postulated ‘true’ dimer. Consequently, the catalytic center activity of this 
structure could be at most (assuming all other subpopulations to be inactive) 3-
times the activity of the monomer. 
In a GPCR like rhodopsin which does not constitutively dimerize in 
detergent, an accurate estimation of G protein activation rates due to the 
physiological dimer can only occur when the correct dimeric interface between 
the 2 rho in a NABB can be detected (for example, by using high-resolution EM 
techniques). Our method presented here cannot conclusively determine the rate of 
the putative physiologically relevant rho dimer. We proceeded by assuming that 
the aforementioned dimer is a part of the mixture of rho configurations that we 
detect using electron microscopy. Thus, we provide a conceptual model for the 
possible limits of G protein activity of a GPCR dimer in a NABB compared with 
a monomer. 
5.3.4 Rho Dimerization is an Assay Dependent Phenomenon  
We have offered proof in this chapter that rhodopsin does not form 
constituitive dimers when reconstituted into NABBs from a detergent solubilized, 
purified state. Our EM studies also show that any detergent-based in-vitro dimer 
or oligomerization based functional assays must take into account the relative 
orientation of the GPCRs, in order to be meaningful.  
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What is the cause of the underlying artifacts associated with detergent 
solubilized membrane proteins, specifically regarding their tendency to adopt an 
anti-parallel orientation? One explanation takes the topological asymmetry of 
biological membranes, and its subsequent disruption, into account. The 
asymmetry of native membranes of membrane proteins is manifested by 
differential distribution of phospholipids between the two leaflets of the bilayer. 
The lipid arrangement provides the membrane proteins not only with maximum 
interaction forces with phospholipids but also with additional stability of their 
quarternary structure (Klingenberg 1981). After detergent solubilization, the 
asymmetric environment of the membrane is lost, as the detergent forms a micelle 
around the membrane protein. The uniform detergent may not allow a differential 
binding of molecules to different parts of the protein. The absence of this 
differentiation may cause instability of detergent-solubilized proteins, forcing 
them to form an anti-parallel (non-physiological) orientation to satisfy the 
hydrophobic interactions in their structure. A similar argument of satisfying 
hydrophobic interactions between two rho monomers may be used to explain why 
two rhodopsins incorporated in a NABB adopt an anti-parallel arrangement. If the 
extent of hydrophobic contacts and other non-covalent forces in a physiologically 
relevant, parallel rho dimer were sufficiently strong, it would have resisted the 
need to reorient itself in detergent.  
Rhodopsin reconstitution in asolectin produced self-associated, symmetric 
oligomers (Mansoor, Palczewski et al. 2006). However, this phenomenon is not 
unique to rhodopsin and seems to be a property of the lipid mixture comprising 
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asolectin (24% saturated, 14% mono-unsaturated and 62% polyunsaturated) at a 
certain lipid to protein ratio only which is not generally applicable to other lipids 
(e.g- egg PC, POPC, DMPC) (Huang, Bayley et al. 1980; Niu, Kim et al. 2002). 
Biophysical and Molecular Dynamics of rhodopsin with a range of lipids 
(Botelho, Huber et al. 2006) (Periole, Huber et al. 2007), has shown that the 
hydrophobic mismatch between lipid chains and the rhodopsin transmembrane 
region, as well as local deformations in the bilayer thickness as a result of 
accommodation of phospholipids to the hydrophobic and polar faces of 
rhodopsin, drive rhodopsin aggregation. Finally, it has been proposed that some 
experiments consisting of cellular overexpression of GPCRs may have 
overestimated dimerization due to transient, non-specific protein contacts (James, 
Oliveira et al. 2006). In our approach, we isolated and purified two rhodopsins in 
close proximity (less than 10nm apart) using NABBs. However, this is possible 
due to excess rho present during NABB formation (Table 2), and limited by the 
diameter of a NABB. 
Comparisons of dimerization potential of rhodopsin (and other family A 
GPCRs) with GPCRs that are currently known to form strong dimers (Romano, 
Yang et al. 1996; Kaupmann, Malitschek et al. 1998) and higher order oligomers 
(Guo, Urizar et al. 2008) are often made in support of the rhodopsin dimer model. 
However such comparisons are not strictly valid since most of the latter GPCRs 
possess distinct structural elements that facilitate dimerization. These elements 
include extended N termini, folded into distinct motifs, as well as extended C-
termini (Bockaert and Pin 1999; Bockaert 2003). The constitutive homo or 
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heterodimers are often disulfide linked or associated with their large extracellular 
domains which include the ligand binding site. These structural features and 
phenomena have not been reported in rhodopsin.  
Another major factor that tends to be overlooked in comparative reports 
between rhodopsins and other GPCRs is the issue of GPCR trafficking to the cell 
surface. For instance, in the case of one of the best known GPCR dimers, the 
GABAB receptor, two isoforms GABABR1 (GBR1) and GABABR2 (GBR2) 
dimerize to form the functional receptor (Jones, Borowsky et al. 1998; 
Kaupmann, Malitschek et al. 1998; White, Wise et al. 1998). When the isoforms 
are expressed alone in cells, GBR1 is retained intracellularly (Couve, Filippov et 
al. 1998) while GBR2 is transported to the surface but cannot bind GABA or 
initiate signaling (White, Wise et al. 1998). It is hypothesized that GBR2 acts as a 
molecular chaperone that masks the ER retention signal of GBR1 using the C-
terminal end thus allowing transport of the dimer to the cell surface in a functional 
form (Margeta-Mitrovic, Jan et al. 2000). In contrast, rhodopsin is trafficked from 
rod inner segments (site of synthesis) to mature rod outer segments (ROS) in the 
retina using a specialized pathway involving a series of coordinated fusions 
(Boesze-Battaglia 2000). This process of fusion is likely optimized for high 
density of rhodopsins that is required for close to single-photon sensitivity to dim 
light.  
From our experiments, we deduce that dimerization of rhodopsin may not 
be required for transducin activation. It is, however, interesting to speculate 
whether oligomerization of other GPCRs has been an evolutionary process that 
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may have led to fine-tuning of the G protein signaling rate in cells. A 
computational study of possible dimeric interfaces of GPCRs using a chimeric 
muscarinic M3 and adrenergic 2 receptor system predicts a parallel orientation of 
the third intracellular loop (IL 3) in each monomer, with the orientation preserved 
even across different putative dimerization interfaces (Gouldson, Higgs et al. 
2000). This may have important functional consequences in terms of G protein 
interaction with this domain. Interestingly, the arrangement of transmembrane 
helices in the helix IV-V rho dimerization model (Fig. 1-4) does not appear to be 
one of the several possible of the dimerization motifs presented. 
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6.0   
Chemokine Receptor 5 (CCR5) Incorporation and 
Activity in NABBs 
6.1 Introduction 
Chemokine receptor 5 (CCR5) is a clinically important GPCR but only 
limited experimental reports exist about its molecular mechanism in a purified, 
cell-free state (Mirzabekov, Bannert et al. 1999; Stenlund, Babcock et al. 2003; 
Navratilova, Dioszegi et al. 2006). The lack of information about CCR5 
compared with other membrane proteins may be due to the inability to get high 
amounts of CCR5 for purification and in-vitro studies. CCR5 requires unique 
posttranslational modifications for function (Farzan, Mirzabekov et al. 1999), 
which varies depending upon the cell type used for heterologous expression. 
CCR5 also shows a marked loss of activity when purified in detergents 
(Mirzabekov, Bannert et al. 1999). We have previously shown that rhodopsin 
exhibits a significant increase in thermal stability when reconstituted into NABBs 
(Banerjee, Huber et al. 2008). We reasoned that NABBs may be the ideal 
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platform for in-vitro studies of CCR5 by providing the detergent-labile receptor a 
stable, soluble, lipid environment for biochemical assays.  
CCR5 has many known ligands (Rossi and Zlotnik 2000), but the most 
well-characterized agonists are RANTES, MIP-1  and MIP-1 . These ligands are 
able to suppress HIV-1 infection in-vitro (Wilkinson 1996; Princen and Schols 
2005). While RANTES is basic at physiological pH, MIP-1  and MIP-1  are 
acidic under those conditions. However all three interact with CCR5. In-vitro 
receptor binding and activation studies show a large overlap in receptor and 
chemokine specificities. This effect is not echoed in-vivo according to gene 
knockout and antagonist assays (Gerard and Rollins 2001; Proudfoot 2002). 
Traditional methods of screening receptor activity use radiolabeled ligands or 
nucleotide, which are hazardous, costly and cumbersome to use. We made use of 
a recently developed fluorescent GTP analog (McEwen, Gee et al. 2001) to 
design an assay that is able to detect ligand mediated G protein activation. The 
ideas and methods presented in this chapter will enable us to answer pertinent and 
long-standing questions about the effect of G protein on binding affinity of CCR5 
ligands and differential activation of G proteins by different chemokines.  
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Figure 6-1. Sandwich-ELISA Strategies used for Characterizing 
CCR5-NABBs  
 
Sandwich ELISA uses dual epitopes on the CCR5-NABB in a 
high-throughput, antibody-based screening protocol. The two antibodies 
are selected based on the assay performed. The fluorimetric quantitation is 
made possible by a colorless substrate that is converted into a fluorescent 
product by a catalytic reaction of Horseradish peroxidase (HRP) in the 
presence of excess H2O2. (A) 2D7 / 1D4 ELISA. The capture antibody is 
2D7, a conformation sensitive antibody to the extracellular side of CCR5.  
The amount of correctly folded CCR5 bound to 2D7 is detected by 
probing with HRP-tagged 1D4 antibody, which recognizes a linear epitope 
engineered at the C-terminus of CCR5. (B) 6xHis / 1D4 ELISA. The 
capture antibody is a hexa-histidine (6xHis) tag recognizing antibody that 
binds to His tags present on zap1 which form NABBs. The amount of 
NABBs containing CCR5 (or any other 1D4-epitope tagged receptor) is 
detected by probing with 1D4-HRP antibody. (C) 1D4 / 6xHis ELISA. 
Switching the order of antibodies in (B) results in an assay that estimates 












6.2.1 Rapid Incorporation of CCR5 into NABBs 
A stable cell line was established and used for the purpose of optimizing 
incorporation of CCR5 into NABBs. HEK-293 cells were labeled with FITC 
conjugated anti-CCR5 antibody and the highest expressing clone (R5-18) was 
selected and amplified. Unlike rhodopsin, CCR5 does not have a characteristic 
spectroscopic signal. Therefore, to characterize CCR5 incorporation into NABBs, 
we first developed a high-throughput sandwich ELISA assay (Fig. 6-1). We 
designed the screen to quantify both the correctly folded CCR5 in NABBs as well 
as total CCR5 using different antibodies commercially available for CCR5 in 
order to detect nanomolar concentrations of CCR5.  
We were able to incorporate CCR5 in NABBs starting from cell-pellets 
derived from 6-10 10 cm diameter (approx. 314 cm2 area) plates. The cells were 
lysed in a mixture of lipids and detergents that has been reported to preserved 
CCR5 stability (Navratilova, Sodroski et al. 2005; Navratilova, Dioszegi et al. 
2006). The CCR5 fraction was enriched using 1D4-sepharose beads and the 
buffer was exchanged to buffer H1 containing POPC/POPS and CHAPS.  
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Figure 6-2. Gel-filtration of CCR5-NABBs  
 
Gel-filtration chromatography of CCR5-NABBs made by Extracti-
Gel D mediated detergent removal (Method 2.24) using NBD-DOPE 
doped POPC on a Superose 6 PC 3.2/30 column on an Akta Explorer 10 
FPLC system. Absorption at two wavelengths was recorded 
simultaneously: 280nm (protein absorbance), 460nm (NBD-DOPE 
absorbance) indicating elution of total protein and lipid from the column. 
The eluted fractions were analyzed by sandwich ELISA, using 2D7 as the 
capture antibody and 1D4-HRP as the probe. Since 2D7 is a conformation 
sensitive antibody, the ELISA profile indicates the amount of correctly 
folded CCR5 in the eluted fractions. The basal response was calculated 
using empty NABBs, prepared under identical conditions and assayed on 
the same ELISA plate at similar protein concentration. 
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The CCR5 was eluted with 1D5 nonapeptide, and purified zap1 was 
added. Detergent removal from this solution was done by passing over an Extracti 
Gel-D resin, yielding NABBs, as determined by a single peak in the gel-filtration 
step (Fig. 6-2). Correctly folded CCR5 was detected in the fractions using ELISA 
with 2D7 capture and 1D4 probing. 2D7 recognizes a split epitope on the 
extracellular side of CCR5 when parts of the epitope are spatially close, and is 
therefore considered to bind to the correct conformation of CCR5 (Khurana, 
Kennedy et al. 2005). 
The CCR5 elutes at the molecular weight region (retention volume) 
characteristic of NABBs, as well as at higher molecular weight regions using a 
Superose 6 column. The cumulative signal of CCR5 in fractions 2-4 is higher than 
the CCR5 signal in fraction 5 (NABB peak). This distribution indicates that most 
of the CCR5 may be incorporated in larger discs, or multiple CCR5 may have 
been incorporated in the NABBs. The latter possibility is less likely given the 
high NABB / CCR5 ratio used for NABB formation (>100:1), unless CCR5 forms 
constitutive dimers in detergents used for cell lysis.  
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Figure 6-3. Conformational Stability of CCR5 in NABBs 
 
Conformational stability of the extracellular side of CCR5 after 
exposure to different detergents was determined by a sandwich ELISA 
using 2D7 and 1D4 (Fig. 6-1 A, Method 2.25). HEK-293 (clone 18) cell 
aliquots were lysed using Buffer (20mM Tris pH 7, 150mM NaCl, 1mM 
EDTA) supplemented with detergents (1% w/v) and lipids (1% w/v total 
lipid) as shown at 4°C for 1 h. The samples were incubated at room 
temperature for 30 min before loading on the 96-well plate. Sample 2 was 
kept in a 95°C water bath immediately after lysis for 5 min, followed by 
30 min room temperature incubation. Sample 7 was processed from a cell 
aliquot lysed under conditions of Sample 1, followed by detergent removal 

















6.2.2 Detection of correctly folded CCR5 in NABBs 
We optimized an ELISA protocol where the antigen (CCR5-NABBs) was 
sequentially sandwiched between two antibodies recognizing specific, distinct 
epitopes on the CCR5-NABB assembly. 2D7 is a monoclonal antibody that has 
been shown to recognize a split epitope on the extracellular side of CCR5 only 
when the epitopes are in proximity to each other (Wu, LaRosa et al. 1997; 
Khurana, Kennedy et al. 2005), which would be the case in a correctly folded 
form of CCR5. Heat denaturation abolishes 2D7 binding to CCR5, and the 2D7 
binding may be competitively inhibited by chemokines. 1D4 monoclonal antibody 
recognizes an engineered linear amino-acid sequence at the C-terminal tail of 
CCR5. We measured the binding of CCR5-NABBs to 2D7 (capture antibody) as 
an indication of correctly folded CCR5. The amount of CCR5 bound to the 
capture antibody was measured by detecting the binding of the second antibody– 
HRP-linked 1D4, and adding a fluorogenic HRP substrate in the microplate wells. 
The sandwich ELISA data is shown in Fig. 6-3. Equivalent volumes were used 
for each sample. 
 To measure total amount of CCR5 in NABBs, 1D4 antibody was used as 
the capture antibody and HRP-linked hexa-histidine binding antibody (6H) was 
used as the detection antibody to recognize the hexa-histidine tag on zap1. HEK 
cells solubilized in buffer containing dodecyl maltoside (DDM), CHAPS and a 
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1:1 (w/w) mixture of DOPC and POPC lipids gave the highest ELISA signal 
(sample 1). Heat treatment of this sample, followed by thawing at room 
temperature destroyed binding to 2D7 antibody (sample 2). Sample 2 served as a 
negative control for this ELISA, since it shows that the final ELISA signal is due 
to specific initial binding to 2D7, and not because of non-specific binding to the 
microplate well. Heat denaturation of CCR5 destroys the native conformation of 
the extracellular loops (including ECL 2) resulting in loss of binding to 2D7. We 
also tested solubilization conditions where different detergents were used 
(samples 3-6) at 1% (w/v) concentrations. At these concentrations, all the 
detergents studied were above their CMC values. The samples were incubated for 
30 min at room temperature. DDM was seen to be the best detergent for 
stabilizing the 2D7 epitope, with a signal that was 65% of sample 1. 
Reconstitution of a sample solubilized in conditions identical to sample 1 into 
NABBs using POPC and zap1 (Method 2.24) gave a signal that was 92% the 
signal of sample 1. The ELISA data implies that rapid incorporation of CCR5 into 
NABBs preserves the native conformational state of the receptor. It should be 
mentioned that there is likely to be a difference in the extent of antibody binding 
by receptors in detergent and in NABBs. We expect the binding of receptor in 
NABBs to be less than that of receptor in detergent micelles because of lesser 
accessibility of the epitope to the antibody, and the charged phospholipids 
headgroups. If this binding difference is considered, then the signal of sample 1 
and sample 7 will be virtually identical. 
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Figure 6-4. Ligand Mediated Activation of CCR5 in NABBs 
 
CCR5 activation of G protein was measured by binding of a 
fluorescently labeled nucleotide analog BODIPY-FL-GTP S. BODIPY-
FL-GTP S binds to activated G protein and undergoes an increase in 
fluorescence quantum yield. The fluorescence increase of BODIPY-FL-
GTP S was measured using CCR5-NABBs with or without ligand. (A) 
Change in BODIPY-FL-GTP S fluorescence using CCR5-NABBs and 
different G protein components is shown in the absence or presence of 
ligand (RANTES). Rhodopsin-NABBs and holotransducin were used as a 
positive control. Gi1 -subunit (Gi1 ) was heterologously expressed and 
purified from E. coli (Method 2.8.1). Holotransducin (Gt) was isolated 
from bovine retinae (Method 2.5), and transducin beta-gamma subunits 
(Gt ) were derived from holotransducin (Method 2.6). Fluorescence 
intensity was calculated relative to that of a mixture of G protein and 
empty NABBs. (B) Specific RANTES mediated increase in G protein 
activity derived from panel A.  
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6.2.3 Ligand-mediated G protein Activity of CCR5 in NABBs 
A fluorescent, non-hydrolysable, non-radioactive GTP analog was used to 
measure guanine nucleotide exchange by the G-protein in the presence or absence 
of ligand-stimulated receptor. The BODIPY-FL-GTP S (B-GTP S) nucleotide 
undergoes an increase in fluorescence quantum yield upon binding to the G-
protein -subunit (McEwen, Gee et al. 2001). The fluorescence increase occurs 
presumably due to de-quenching of the fluorophore from the guanine ring, which 
occurs in the extended conformation of the nucleotide when it resides in the 
nucleotide binding pocket. The maximum increase in quantum yield of B-GTP S 
upon binding to Gi1  has been reported to be 3-4 times over B-GTP S alone. 
Unlike (unlabeled) GTP S, binding of B-GTP S has been hypothesized to form 
an intermediate activated state of Gt between the inactive and fully-activated 
states (Ramachandran and Cerione 2004). The nucleotide may be used to follow 
the steady-state enzyme kinetics of the G  subunits (Jameson, Roof et al. 2005). 
In this case, we adapted the reagent concentrations and reaction time to enable us 
to monitor increase in fluorescence of B-GTP S in an end-point assay. The assay 
was optimized using rhodopsin-NABBs and holotransducin. 
CCR5 is known to couple to the Gi class of G-proteins (Cardaba, Kerr et 
al. 2008). We observed efficient G-protein activation by CCR5-NABBs in the 
presence of the heterotrimeric Gi protein, as well as holotransducin. Stimulation 
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of CCR5 in NABBs by 50mM RANTES produced upto 30% enhancement of B-
GTP S binding to the G protein, compared with unstimulated CCR5-NABBs 
(Fig. 6-4). The largest increase in BODIPY-FL-GTP S was seen when  
subunits from transducin were mixed in equimolar ratio with E. coli expressed 
and purified Gi1 . The E. coli expressed Gi1  subunit used in this experiment did 
not contain post-translational modifications (prenylation or myristoylation) that 
are present in native G  subunits. The results indicate the requirement of a 
heterotrimeric G protein to observe the activity of CCR5. The -subunit of the G 
protein is mostly in contact with the cytoplasmic side of the GPCR. However, 
CCR5 does not seem to couple efficiently with Gi  alone. We noticed a 
requirement of the  subunits for efficient activation of the G protein  subunit. 
In our assay, the role of  subunits may be to increase the accessibility of the Gi1 
 subunit to the NABB due to the lipid anchor present on the -subunit. 
Isoprenylated peptides have approximately 10-fold higher affinity for lipids than 
their unmodified versions (Silvius and l'Heureux 1994). The 1 subunit (present in 
transducin) contains a farnesyl (15 carbons) modification at its C-terminus. Other 
-subunits have geranygeranylations (20 carbons) at the same location 
(Wedegaertner, Wilson et al. 1995). It is also plausible that the -subunits 
modulate an increase in the receptor mediated GTP uptake by the -subunit by 
affecting the conformational change in the G protein.  
We detected B-GTP S uptake in the presence of unstimulated CCR5-
NABBs (Fig. 6-4 A). A certain basal level of constitutive GPCR activity is 
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common for GPCRs in the absence of an inverse agonist (Bartfai, Benovic et al. 
2004). Under the conditions of our assay, a 10-15% greater binding of B-GTP S 
was seen in the presence of CCR5-NABBs without ligand compared with empty 
NABBs alone. Samples with RANTES showed a significantly higher increase in 
signal.  
6.3 Discussion 
6.3.1 A General Incorporation and Detection Strategy for Expressed 
Membrane Proteins into NABBs 
Unlike rhodopsin, CCR5 and other known GPCRs do not contain an 
internal chromophore with which to accurately estimate their concentration in a 
mixture of other proteins. We therefore chose to work in small volumes for 
NABB formation (50 – 100 μL) and make the concentration of NABBs high 
enough such that there are always excess of empty NABBs compared to 
membrane proteins in that volume. Using this approach, we can approximate that 
most, if not all, membrane proteins in the cell lysate will be incorporated into 
NABBs. The GPCR containing NABBs were then isolated using immunoaffinity 
purification. We have also refined this method by adding a short immunoaffinity 
step for the GPCR prior to NABB formation. This modification enabled us to 
work with larger volumes of lysate and higher concentrations of the GPCR, as 
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well as do a convenient buffer exchange from the cell lysis buffer to the NABB 
formation buffer while the  GPCR was on the solid immunoaffinity bead support. 
The method developed for rapid incorporation of CCR5 in NABBs may be 
generalized to other membrane proteins that are expressed in cells at similar or 
higher levels. The method is also scalable to larger volumes, using the same 
strategies of cell lysis, initial enrichment, NABB formation, final purification, and 
antibody-based characterization.  
Conventional methods of characterization of macromolecular protein 
complexes commonly involve SDS-PAGE and immunoblotting. In these methods, 
any information about activity is lost and quantitation of the signal is difficult, and 
relatively few samples may be analyzed simultaneously. We developed a 
sandwich ELISA technique which may be easily adapted to different membrane 
proteins in NABBs by using appropriate antibodies. The screening process was 
adapted for a microplate due to which many conditions may be analyzed in 
replicates in a rapid and quantitative way. We chose an antibody (2D7) that 
recognizes the biologically relevant conformation of CCR5 in order to analyze the 
amount of active receptor incorporated in NABBs. 2D7 has also been shown to 
effectively compete with RANTES and gp120 from HIV for binding to CCR5 
(Wu, LaRosa et al. 1997; Rossi and Zlotnik 2000; Zhang, Rao et al. 2007). This 
property enables us to focus on those conditions that are most likely to yield 
CCR5-NABBs which can be analyzed for relevant biological assays. 
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6.3.2 G protein Activation by CCR5-NABBs 
The presence of G protein may serve to modulate ligand affinity in the 
GPCR, probably by making high-affinity sites accessible to agonist (Whorton, 
Bokoch et al. 2007). In-vitro assays of small-molecules affecting ligand binding 
to CCR5 in the absence of G proteins may not be accurate in predicting the in-
vivo effects. A series of cell-based and membrane-based assays have determined 
that CCR5 couples to both Gi as well as Gq class of G proteins (Mueller, 
Mahmoud et al. 2006; Springael, de Poorter et al. 2007). Whether a CCR5 
facilitated HIV infection involves G protein signaling by CCR5 is not resolved 
(Gosling, Monteclaro et al. 1997; Kinter, Catanzaro et al. 1998). Further, CCR5 
has been shown to interact with CD4 and CXCR4 in assays where HIV entry is 
accompanied by either Gi or Gq signaling (Lin, Mettling et al. 2006; Harmon and 
Ratner 2008). However, there have been no reports of assays of CCR5 with 
purified G proteins. The BODIPY-FL-GTP S binding assay presented here is a 
convenient and rapid method to assay for effector mediated G protein activation 




7.0  Future Perspectives 
7.1 Introduction 
Nanoscale, water-soluble, well-defined lipid bilayer particles like NABBs 
have tremendous potential in a variety of applications in spectroscopy, cell-
biology and medicine. Based on work done by other groups on similar nanoscale 
structures and membrane proteins, and our own data and experience, this chapter 
presents the near and long term experimental approaches that will be made 
possible using NABBs. 
7.2 Novel Assay Development  
7.2.1 Infra-Red Spectroscopy of Membrane Proteins 
Fourier transformed infrared spectroscopy (FTIR) difference spectroscopy 
is a widely used technique to investigate secondary structure and conformational 
changes upon interaction with substrates (Fahmy, Siebert et al. 1995; Siebert 
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1995; Zvyaga, Fahmy et al. 1996). However, the standard FTIR technique 
(transmission mode) is limited to studying thin films to avoid the strong 
background IR absorbance of water. FTIR in an attenuated total reflection (ATR) 
mode solves this problem and allows for solvent accessibility to the protein. But 
FTIR-ATR studies too have been limited by difficult sample preparation (poor 
protein film formation, hydration induced swelling of sample and lack of 
preservation of protein native state). The signal to noise ratio in a typical FTIR-
ATR experiment is sufficient to study protein multilayers but not monolayers. 
Surface enhanced infrared absorption spectroscopy (SEIRA) is a modification of 
the FTIR-ATR method that can reliably measure spectra in protein monolayers 
(Ataka and Heberle 2006). The SEIRA technique involves enhancement of the 
interaction of IR by the sample with surface plasmons (collective electronic 
oscillations from a colloidal metal film). The signal enhancement is restricted to 
8-10 nm above the colloidal metal surface; therefore the bulk solution is not 
enhanced. The enhancement of signal is affected by the size, shape and proximity 
of the protein ‘islands’ to the metal film, provided that the islands are smaller than 
the wavelength of IR light (15-30 nm). 
For SEIRA measurements, a colloidal gold film is used as the surface. The 
surface is often modified with linkers to avoid protein denaturation and to provide 
selective protein orientation for measurements. The gold film used for SEIRA 
may be conveniently modified with Ni-NTA groups. The NABB system meets all 
the criteria to be an ideal sample for SEIRA studies. They are small in size, may 
have a high concentration of proteins incorporated per NABB and the zap1 is 
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histidine tagged, which can easily bind to a Ni-NTA surface. Accessibility to both 
sides of the incorporated receptor is preserved for studies of complex 
conformational changes. Initial experiments with rho-NABBs have shown that the 
NABBs oriented parallel to the gold surface (probably due to two his tags per 
NABB), and no significant loss in the rhodopsin IR spectrum was detected (Vogel 
R- unpublished results). 
7.2.2 Single-molecule Fluorescence of GPCRs 
‘Nanosizing’ a traditional bulk-phase assay may lead to previously 
unanticipated results. For example, a notable decrease in G protein activation 
rates was reported in the presence of excess ‘empty’ HDL particles in assays 
where rhodopsin were incorporated in HDL-like nanodisc particles (Bayburt, 
Leitz et al. 2007). The reason of the lower rate of activation was hypothesized to 
be partitioning of Gt into empty NABBs. Using 2-adrenergic receptor monomers 
in HDL particles, and in the absence of empty HDL particles, only 6% of the total 
Gs was bound to 2-AR containing HDL particles (Whorton, Bokoch et al. 2007). 
In this case, it was hypothesized that excess Gs precipitates in the absence of 
sufficient number of HDL particles, probably due to the hydrophobic 
modifications present on Gs. In our experience with ensemble G protein assays 
with rho-NABBs, we observed lower activation rates in the presence of empty 
NABBs using the Trp fluorescence assay. Using the high-throughput BODIPY-
FL-GTP S assay with CCR5-NABBs, we did not observe a significant change in 
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G protein activation in the presence or absence of empty NABBs. Further, our 
control experiments using rho-NABBs did not show any difference in the basal 
BODIPY-GTP S binding rate of Gt in buffer alone or Gt in the presence of empty 
NABBs (Grunbeck A- unpublished data).  
Fluorescence measurements carried out at single-particle resolution can 
provide information of structural distributions in a direct fashion, since emitted 
photons from individual molecules can be recorded and analyzed. The molecular 
systems can be studied in a molecule-by-molecule manner, which enables 
evaluation of biological processes in a model-free fashion (Mukhopadhyay and 
Deniz 2007). The well-defined structure of NABBs and the ability to study 
individual GPCRs either under constant flow conditions or by tethering the 
NABBs to a functionalized surface make this an ideal system for single-molecule 
fluorescence assays.  
Single-molecule fluorescence studies also require the use of a novel class 
of fluorophores that are photostable to intense laser excitation and do not form 
non-emitting triplet states upon excitation (Eggeling, Fries et al. 1998). We have 
used the Atto-655 dye for derivatization of rhodopsin (Chapter 4), which is part of 
a series of dyes that fulfill the characteristics above and are hence ideally suited 
for single-molecule fluorescence studies. Atto-655 is an oxazine-backbone based 
dye that has lower molecular weight than most commercially available dyes that 
are fluorescent at long wavelengths. The Atto dyes have been reported to show 
significantly lower self-quenching, and have a rigid backbones that do not show 
cis-trans isomerization common to cyanine based fluorophores (usually, only the 
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trans conformation of a fluorophore is responsible for its fluorescence properties). 
Quantitative studies of GPCRs in NABBs will thus depend on a combination of 
ensemble assays like those presented in the preceding chapters, alongwith single-
particle techniques using appropriate fluorophore reporters, to understand signal 
transduction events at a level proximal to the GPCR.  
7.3 Future Research Aims 
7.3.1 G protein Effects on Ligand Affinity of a GPCR 
How can we detect a small change in ligand affinity of a GPCR under the 
influence of purified G proteins using an ensemble fluorescence assay? When 
fluorescently modified ligands are available (for example, RANTES for CCR5), 
the sensitive technique of fluorescence anisotropy may be used to determine even 
small changes in the anisotropy of the labeled ligand (in this case, a chemokine). 
In a homogeneous solution the ground-state fluorophores will all be randomly 
oriented. When exposed to polarized light, those fluorophores which have their 
absorption transition moments oriented along the electric vector of the incident 
light are preferentially excited (Lakowicz 1999). Hence, the excited state 
population is no longer randomly oriented. Depolarization of emission can be 
caused by a number of phenomena. Depending upon the conditions of this type of 
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experiment, depolarization may be chiefly be determined by the rotational 
diffusion of the fluorophore (attached to the ligand).  
 
To measure fluorescence anisotropy (r), the sample is excited with 





where, I||  is the measured intensity when the emission polarizer is oriented 
parallel to the direction of the polarized excitation, and I  is the measured 
intensity when the polarizer is perpendicular to the excitation polarization. 
The labeled molecule is considered a spehere for the purpose of 
calculating the average anisotropy in the sample. Following pulsed excitation, the 
decay of fluorescence anisotropy, the decay of fluorescence anisotropy of a sphere 
is given by:  
r(t) = r0e
t /  
where r0 is the anisotropy at t = 0 (also called fundamental anisotropy).  





 where   is the viscosity, V is the volume of the rotating unit,  
  T is the temperature in Kelvin and R is the gas constant. 
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Considering the simplest mode of anisotropy, where the intensity follows 
a single-exponential intensity decay, the expression for measured anisotropy r 
(derived from Perrin equations) (Lakowicz 1999) is: 
r =
r0
1+ ( / )
 
where   is fluorescence lifetime of the fluorophore. If the correlation 
time is larger than the lifetime (  >> ) then r= r0 . If the correlation time is 
shorter than the lifetime (  << ), then r = 0. 
For globular proteins, the rotational correlation time is related to the 







(v + h)  
where v  is the specific volume of the protein (typically 0.73 mL/g) and h 
is the hydration (near 0.23 g of H2O per gram of protein). 
For small fluorophores in a low viscosity solution, the emission is highly 
depolarized because of very low rotational correlation times (determined by 
molecular weight, as described above). The average molecular weight of a 
fluorescently labeled chemokine is 8 kD. Upon binding to CCR5 in NABBs, the 
molecular weight of the fluorophore-containing system increases to around 250 
kD, or roughly 30 times the mass of the fluorescent chemokine alone. The NABB 
not only stabilizes the CCR5, but in this case, adds the required bulk to increase 
the rotational diffusion time of the bound fluorophore resulting in a net increase in 
anisotropy, compared with a free (unbound) ligand. A heterotrimeric G protein 
bound to the CCR5-NABB will increase the molecular mass of the system even 
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further. Using this assay with an appropriately chosen fluorophore, it could be 
possible to detect changes in ligand binding to CCR5 by the relative change in 
anisotropy signal of the fluorophore as a measure of binding affinity to the CCR5-
NABBs. 
7.3.2 Functional Consequences of GPCR Dimerization 
NABBs may be designed to contain one or two GPCRs based on the 
stoichiometry of GPCR to zap1 and lipids. The NABBs are formed by a self-
assembly process mediated by hydrophobic association of the zap1 with the lipid 
acyl chains and extensive salt-bridging between two anti-parallel, amphiphatic 
alpha-helices of zap1, resulting in a soluble, disocidal structure of lipids with the 
GPCR(s) incorporated. NABB assembly starts from a detergent solubilized state 
of GPCR, lipids and zap1, therefore any artifactual aggregation of the GPCR with 
other protein components can be minimized. The NABBs with or without the 
GPCR may be affinity purified on Ni-NTA beads, or the affinity tag on the GPCR 
may be used to obtain high purity of GPCR containing NABBs. In chapter 5, we 
have characterized rhodopsin-NABBs using a variety of biophysical and 
biochemical methods to detect G protein activation by one or two rhodopsins in 
NABBs. We have demonstrated that a GPCR in NABBs has significantly higher 
thermal stability compared to commonly used detergents (Chapter 5, 6). We have 
also developed a method to rapidly incorporate CCR5 in NABBs from solubilized 
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HEK-293 cell membranes, thereby minimizing the exposure of the GPCR to 
detergents (Chapter 6).  
Knowledge of the GPCR oligomeric state responsible for G protein 
activation may be key to a novel class of therapeutic interventions, which perform 
either by blocking GPCR dimerization directly or by modulating G protein 
affinity for one of the oligomeric states. It is difficult to distinguish between 
dimerization requirements for trafficking and for G protein activation using cell-
based assays. NABBs may be used to isolate one or two GPCRs to perform G 
protein activations in ultra small volumes and concentrations of all components. 
7.3.3 Structures of a GPCR–G protein Assembly in a NABB  
The study of membrane proteins in general, and GPCRs in particular, has 
been hampered by the lack of a well-defined, soluble, model membrane. In the 
absence of a membrane, even relatively soluble membrane proteins tend to 
oligomerize or aggregate. On the other hand, if liposomes or detergent micelles 
are used to stabilize proteins, the situation is complicated by these systems’ 
inherent polydispersity, inconsistency and instability. It has therefore been 
challenging to obtain unambiguous information about GPCR structure and 
function experimentally. NABBs may serve as a versatile adjunct to and extend 
the use of conventional membrane technologies.  
Electron microscopy is a powerful emerging field of image-based 
structure deconvolution. Over the last decade, a convergence has taken place 
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between the diverse fields of statistical optics, theory of linear systems, and 
multivariate data analysis and classification with EM imaging (Frank 2002). 
Determination of structure at a biologically meaningful resolution with single-
particle averaging techniques requires a good control of sample preparation 
(homogeneous sample) and classification methods (often more than one method). 
Negative stain EM is useful mainly for revealing only the surface contour of a 
protein (Henderson 1995). This is because predominantly low-resolution 
information is preserved by the negative stain due to the limitations associated 
with embedding a biological sample in a heavy-ion based high contrast medium. 
While we were able to perform a visual classification using negative-stained 
NABBs (Fig. 5-4), the lipoprotein particles had sufficient heterogeneity in shape 
to be intractable to more rigorous statistical analyses or structure prediction 
(Appendix Fig. A). In cryo-EM, the molecules are entrapped in their native 
orientation in a layer of vitreous ice. The densities measured in cryo-EM reflect 
the projections of the biological material without any staining agent around the 
particle. However, while using charged lipoproteins like NABBs made with 
POPC as the lipid, the strong electron density of the lipid headgroups overwhelms 
the densities of proteins that are not sufficiently separated from the lipid bilayer. 
Cryo-negative staining may be a promising technique that would reverse the 
strong electron density of the lipid headgroups under cryo-EM conditions, and 
allow acquisition of medium to high resolution structural data of membrane 
proteins incorporated in these discoidal lipoprotein particles.  
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NMR spectroscopy is a complementary technique to X-ray 
crystallography for high resolution structure determination. NMR of discoidal 
lipoprotein complexes presents the challenge of long rotational correlation times 
of the relatively large sizes of lipoprotein complexes to be solved by solution 
NMR. Solid-state NMR (SSNMR) has evolved as a powerful tool for structural 
studies of protein and large complexes with slow tumbling rates. The limitation of 
using isotope labels at a small number of sites on a protein in SSNMR has been 
overcome in the last decade by the introduction of high magnetic field (greater 
than 14 Tesla) and high-frequency magic-angle spinning (MAS) in combination 
with multi-dimensional dipolar recoupling sequences (Opella and Marassi 2004). 
NMR on lipoprotein particles has been successfully performed (Li, Kijac et al. 
2006; Mishra, Anantharamaiah et al. 2006) although full assignments of the peaks 
have not been reported in the case of membrane protein embedded in these 
structures (Kijac, Li et al. 2007). 
7.3.4 Tailoring Apolipoproteins to form NABBs of Diverse Properties 
Apolipoproteins are called protein detergents for their unique ability to 
form defined discoidal lipoprotein complexes. How can the properties of apo A-I 
be modulated to form discs that have long-term stability, or are able to be 
triggered to fuse and deliver their cargo (for example, to a Giant Unilamellar 
Vesicle)? The amino-acid sequence of apo A-I is well-conserved throughout 
evolution. Exploring apo A-I sequences of animals that evolved differently may 
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provide us with clues as to which regions in the sequence may be critical for 
stability of the structure. In one such attempt, the lipid binding helical stretches in 
human apo A-I were repeated in different numbers to form a series of engineered 
constructs called Membrane Scaffold Protein (MSP) series by the Sligar group 
(Denisov, Grinkova et al. 2004). However, the net effect of these duplications was 
not observed on the weighted salt-bridging scores, indicating that this strategy 
may not be sufficient to increase disc stability. Methods to detect small changes in 




3D Model of 2Fab-rho-NABB from Negative stain EM images 
The EMAN suite of programs (Lüdtke, Baldwin et al. 1999) was 
used to determine a preliminary structure of purified 2Fab-rho-NABBs 
(Chapter 5). 12 electron micrographs were used to select 516 single 
particles using the Boxer program. The defocus of the micrographs was 
approximately  
-5 μm. The selected particles were arranged into 8 class averages, and 
these classes were averaged to give the final model as shown. A C6 axis of 
symmetry perpendicular to the plane of the assumed disc was imposed 
during calculation of the 3D model in order to converge the calculations to 
form a cylindrical shape. The volume errors arising from the ‘common-
lines’ approach to calculating the structure was not corrected for. The 
model was not refined any further. 
A barrel shape of the 2Fab-rho-NABB complex can be seen. The 
outline of the NABB can be discerned from the structure. The smear of 
density above and below the plane is likely due to C6 symmetry imposed 





Sandwich ELISA Calibration using Rho-NABBs 
Detection of 1 rho-NABBs may be done using the sandwich 
ELISA technique (Chapter 6). 6xHis antibody was used to capture NABBs 
and 1D4-HRP was used to detect the rhodopsin present. (A) Scatter plot of 
log of the rho concentration in NABBs in each well (x-axis) vs the 
percentage of the maximum fluorescence intensity obtained. Each point is 
the average of 4 wells. Black points show binding of 1D4 purified 1 rho-
NABB (from a 0.01 rho/NABB sample) and red points show binding of 
0.01 rho/NABB (including excess NABBs) to 1μg/mL of 6xHis antibody 
inside the microplate wells. Rho-NABBs compete for 6xHis binding with 
empty NABBs as seen by the requirement of higher rho concentration to 
achieve the same signal when excess empty NABBs are present (red). (B) 
Image of the microplate region corresponding to the black data points in 
(A) using a Typhoon 9400 scanner showing the fluorescence intensity of 
the Amplex Red product as a function of rho concentration. The sample 
plate was prepared by serially diluting 10nM of rho in NABBs (rightmost 
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